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ABSTRACT 
 
We hypothesized that at low doses (<2.0 kGy) electron beam processing, a non-thermal 
food pasteurization technology, would be effective at inactivating the microbial 
pathogens potentially present in raw milk without compromising or degrading its 
composition, nutritional value, and aromatic profiles.  The log10 reductions of 
background microbial populations and inoculated pathogens (Coxiella burnetii, 
Campylobacter jejuni, Escherichia coli O157:H7, Listeria monocytogenes, and 
Staphylococcus aureus) in raw milk was determined. The possible reduction in infection 
risks associated with these pathogens was also quantified using β-Poisson and 
exponential risk assessment models.  After eBeam processing, milk was analyzed to 
determine potential losses in the concentrations of lactose, vitamin B2, vitamin B12, and 
calcium.  Casein and whey proteins were analyzed for signs of breakdown with SDS-
PAGE. Lipid oxidation was measured using the TBARS method, and GC-MS olfactory 
analysis was used to determine changes in the aromatic compound profile.  When 
exposed to 2.0 kGy, the numbers of aerobic and anaerobic microbial populations (8.1 x 
10
4
 and 2.9 x 10
3
 CFU/mL respectively) in raw milk were reduced to below detectable 
limits representing >3.5 and ~2.5 log10-reductions for aerobic and anaerobic 
microorganisms, respectively. At 2.0 kGy eBeam dose, significant reductions in 
predicted lethality of raw milk associated pathogens can be observed (between 13-logs 
and 28-logs).  QMRA illustrated the significant reductions in infection risks eBeam 
pasteurization of raw milk can achieve through pathogen elimination. Without eBeam 
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pasteurization, ingestion of raw milk containing ~40 CFU/mL L. monocytogenes or ~10
3
 
CFU/mL C. jejuni or E. coli O157:H7 would result in ~8/10, ~8/10, or ~10/10 infections 
for these pathogens, respectively. However, if raw milk is eBeam pasteurized at 2.0 kGy, 
the infection risks from consumption would be reduced to ~<1/9.735 million persons. 
Except for vitamin B2 (which showed a 31.57% loss), none of the other targeted 
nutrients were affected at 2.0 kGy. There was no indication of lipid oxidation after 
eBeam processing. However, by day 7 of refrigerated storage, there was a 350% increase 
in lipid oxidation in the 2.0 kGy samples as compared to the non-irradiated samples. 
There were only minimal changes in the aromatic compound profiles after eBeam 
processing. 
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CHAPTER I  
INTRODUCTION  
 
Raw milk is a high-risk food item to consume due to the potential presence of 
pathogenic microorganisms such as Campylobacter jejuni, shiga-toxin producing 
Escherichia coli spp., and Listeria monocytogenes (1).  Pathogens such as these are 
typically introduced into the milk due to either mammary or other 
infections/inflammation (mastitis) affecting the dairy cow, or from sanitary factors 
associated with the milking environment, such as cross-contamination from fecal matter 
or from the human workers (2).  Raw milk and food products made with raw milk (such 
as soft cheeses) have been implicated in numerous foodborne outbreaks that have led to 
several hospitalizations and deaths (3).  Thermal pasteurization of raw milk, a standard 
practice in the milk industry, is designed to inactivate pathogenic microorganisms 
present in milk, thus making milk safe for human consumption.  Milk is considered to be 
a good source of potassium and magnesium, and an excellent source of vitamin B2 
(riboflavin), vitamin B12, and calcium, among other nutrients (4). Thermal pasteurization 
of milk is a low-heat processing treatment and does not decrease milk’s nutritional 
value, particularly its vitamin and mineral content.  Electron beam irradiation is a proven 
non-thermal (cold) pasteurization technology, and is approved by the FDA for the 
processing of certain foods such as fresh produce (5-7).  There are potential benefits to 
exploring the use of non-thermal processing technologies for the pasteurization of raw 
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milk, including an improved creamier (non-cooked) flavor and applications in further 
processed dairy products, particularly those that would normally use raw milk.  
 
The purpose of the studies presented in this thesis was to determine if eBeam processing 
technology is a suitable, non-thermal pasteurization alternative to traditional thermal 
pasteurization of raw milk.  The first study focused on determining if eBeam 
pasteurization of raw milk was effective from a microbiological and public health 
perspective, while the second study focused on determining its effectiveness from a 
nutritive value and aroma sensory perspective. 
 
The objective of the microbiological study was to define achievable log10 reductions of 
raw milk’s indigenous microflora, define D-10 reduction values for select raw milk 
pathogens, and to determine the predicted reduction of public health risks (based upon 
the defined D-10 values) when eBeam processed milk is consumed as opposed to raw 
(non-eBeam processed) milk.  The objective of the nutrient and aroma sensory study was 
to determine the changes, if any, of lactose, calcium, vitamin B2, and vitamin B12 
concentrations before and after eBeam processing. Additional objectives included 
measuring the amount of lipid oxidation occurring due to eBeam pasteurization, 
determining breakdown of casein and whey proteins based upon their molecular weights, 
and determining changes in aroma profile due to eBeam pasteurization.  It was 
hypothesized that eBeam processing at 2.0 kGy is effective for non-thermal milk 
pasteurization while not affecting the nutritional value of such milk.  Additionally, it was 
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hypothesized a 2.0 kGy dose would not affect the aroma profile of eBeam processed 
milk. 
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CHAPTER II  
LITERATURE REVIEW  
 
Raw Milk 
 
Unless the dairy cow has a mammary gland infection, such as mastitis, or a systemic 
disease, raw milk from the udder is considered sterile, free of microorganisms (8).  
However, as milk leaves the udder, bacterial and other microbial contaminants are 
introduced into the milk via cross-contamination from sources such as the teat skin or 
human workers assisting with milking.  Microorganisms are able to survive and 
proliferate in raw milk due to factors such as milk having an approximately neutral pH 
(~6.8), a high water activity (~0.99), and an abundance of nutrients (9-10).  Though the 
majority of microorganisms present in raw milk are not pathogenic and will not cause 
illness to humans if consumed, raw milk is known to harbor pathogens known to cause 
severe illness, and sometimes death, if consumed.  Although anyone can be affected, the 
illness symptoms and other ailments caused by these pathogens are particularly severe 
when consumed by children, pregnant women, the elderly, or other immune-
compromised persons. 
 
 
 
 
 5 
 
Consumption of Raw Milk and Associated Products in the United States 
 
Consuming raw cow’s milk is becoming an increasingly popular replacement to heat-
pasteurized milk (1, 11).  This change of consumer preference is due to many reasons, 
including a “better nutrient” profile as perceived by the consumer and perceived 
“increased probiotic health benefits from the bacteria present in raw milk.  Some 
advocates even suggest raw milk helps treat, prevent, and cure many health related 
ailments, including acne, heart and kidney disease, food allergies, cancer, and lactose 
intolerance (12-13).  However, there is very little scientific research to support these 
claims.  There is not a significant difference in nutritional content between raw and 
pasteurized milk, and the known health risks from consuming raw milk far exceed any 
possible health benefits (1, 14).   
 
The CDC’s Foodborne Diseases Active Surveillance Network Population Survey (2006-
2007) estimated approximately 3% of the U.S. population drank raw milk within the past 
seven days, a slight decrease from the 3.5% estimated in their 2002 survey (3).  
Additionally, it was estimated ~1.6% of the U.S. population consumed cheese made 
from unpasteurized milk, another raw-milk related food vehicle implicated in numerous 
foodborne outbreaks.  The frequency of raw milk consumption among farm families and 
their employees is even greater, with approximately 35% to 60% of such persons 
estimated to consume raw milk (14-15). 
 
6 
Sale of Raw Milk Within the United States 
Since 1987, the FDA has required all milk packaged and sold for human consumption 
through interstate commerce to be pasteurized to protect consumers from these pathogen 
risks.  However, as of January 2016, the sale of raw cow’s milk in intrastate commerce 
remains legal in some capacity in 29 U.S. states, including California, Pennsylvania, and 
Texas (16).  The sale of raw milk in these states is allowed either through retail stores or 
purchase directly on the farm.  The other states do not allow for the sale of raw cow’s 
milk for human consumption, though some allow the sale for non-human consumption 
purposes.  In states in which the sale of raw milk is illegal, some still allow for citizens 
to lawfully obtain raw milk through a cow-share program.  In cow-share programs, an 
individual or group of individuals pay the farmer for boarding, feeding, and milking the 
cow(s) owned.  The milk produced by the cow is then given to the group and is then 
typically consumption.  It should be noted, the incidence of foodborne outbreaks related 
to raw milk are significantly higher in states which allow for the sale of raw milk, further 
supporting the argument raw milk is a high-risk food item to consume (16). 
Rationale of Thermal Milk Pasteurization 
Due to a variety of factors, there is always a certain level of uncertainty pertaining to the 
safety of raw milk.  Even when carefully produced and harvested from disease-free 
cattle, the production environment cannot consistently be completely aseptic.  Heat 
7 
pasteurization, defined as a process to kill pathogenic and other microorganisms present, 
is commonly used in the milk industry to decrease the microbial load of milk and extend 
shelf life.  Heat pasteurization kills the pathogenic bacteria responsible for diseases such 
as listeriosis, campylobacteriosis, typhoid fever, and brucellosis, as well as other 
vegetative pathogens.  This is most commonly accomplished through batch 
pasteurization at 145
o
F (63
o
C) for 30 minutes, or through the high temperature, short
time (HTST) method at 161
o
F (72
o
C) for 15 seconds.  These time and temperature
combinations are implemented in order to achieve a 6.0 log10-cycle reduction of Coxiella 
burnetii, a bacterium implicated as the most heat-resistant, non-sporulating pathogen 
present in milk, known to cause Q-fever in humans (8, 17).  A variety of organizations, 
such as the FDA, CDC, the American Academy of Pediatrics, the National Association 
of State Departments of Agriculture, the Association of Food and Drug Officials, and 
other organizations have endorsed the pasteurization of milk to increase consumer safety 
(18-22).   
Pathogens in Raw Milk and Raw Milk-Made Dairy Products 
Foodborne bacterial pathogens found in raw milk include Salmonella, pathogenic 
Listeria and Campylobacter spp., Shiga toxin-producing Escherichia coli, 
Staphylococcus aureus, and Brucella abortus. Raw milk has been implicated in 
numerous foodborne illnesses and deaths due to consumption of these and other 
pathogens. According to the CDC (23), from 1993-2006, outbreaks linked to raw milk 
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consumption were 150 times more likely to occur than from pasteurized milk.  
Numerous literature reports state outbreaks associated with raw milk have also led to 
chronic illness, deaths, and stillbirths, as reviewed by Oliver and others (1).  The average 
number of outbreaks caused by raw milk quadrupled in 2007-2012 from 1993-2006 (24).  
This can be attributed to the fact that more states are legalizing the sale of raw milk, and 
this increase in legalization positively correlates to the number of raw milk outbreaks.   
Incidence of Foodborne Outbreaks Related to Raw Milk in the U. S.: 1990 – 2016  
The CDC states that from 2007-2012, there were 81 outbreaks attributed to the 
consumption of raw milk reported in 26 states.  These outbreaks caused 979 illnesses 
and 73 hospitalizations (23).  The three pathogens most frequently implicated in these 
cases were Campylobacter spp. (81%), shiga toxin-producing E. coli spp. (17%) and 
Salmonella spp. (3%).  Additionally, the CDC (23) noted the average yearly outbreaks 
count was 4 times higher from 2007-2012 (5 years) than 1993-2006 (13 years). 
Interestingly, ~81% of these reported outbreaks occurred in states in which the sale of 
raw milk was legal.  Table A-1 shows data for raw milk-implicated foodborne outbreaks 
from 1992-2016.  Data were collected from the CDC Foodborne Disease Outbreak 
Surveillance System, published literature, and other outbreak reporting online sites.  
Fifty outbreaks were identified in which the outbreak location, contaminating pathogens, 
and number of illnesses were identified leading to 897 illnesses, 204 hospitalizations, 
and 2 deaths.  Campylobacter spp. was the most frequently-implicated pathogen in these 
9 
outbreaks (52%), followed by shiga toxin-producing E. coli (24%), Salmonella spp. 
(20%) and L. monocytogenes (4%). 
Campylobacter jejuni 
C. jejuni is a helical-shaped, Gram-negative bacterium known to cause
campylobacteriosis (a form of gastroenteritis).  Worldwide, C. jejuni causes more cases 
of gastroenteritis than Salmonella spp. or E. coli O157:H7 (25).  Those who are sickened 
from C. jejuni show acute symptoms such as diarrhea (sometimes bloody), nausea, fever, 
and abdominal cramps, and typically recover within 2 to 10 days (26).  Deaths related to 
C. jejuni are not common (~0.005%) (25).  Long-term sequelae are uncommon with C.
jejuni infection, Guillain-Barré and Reiter syndromes are recognized to occur in ~0.01% 
and ~1.0% of infections (27).  Though most infections arise from handling and 
consuming poultry, consumption of C. jejuni-contaminated raw milk is the most reported 
cause of outbreak infections (25, 28).  Person-to-person transmission is highly unusual, 
particularly because the infectious dose of C. jejuni is relatively high (~800-10
6
 ingested
organisms needed to produce illness) (25).  Heat, such as cooking chicken or thermally 
pasteurizing milk, kills C. jejuni cells. 
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Coxiella burnetii 
C. burnetii is a Gram-negative bacterium that is the causative agent of Q-fever.  The
infective dose of C. burnetii is estimated to be less than 10 bacterial cells (29).  In 2007, 
167 cases of Q-fever were reported in the U.S. (30).  Q-fever is characterized by 
influenza-like symptoms, such as high fevers, severe headaches, chills, nausea, and 
vomiting (30).  Although typically an acute illness that is significantly shortened in 
duration with antibiotics, Q-fever can develop into a chronic illness with complications 
such as pneumonia and granulomatous hepatitis.  Pregnant and other immunosuppressed 
people and those with a pre-existing heart valve defect are most at risk for developing 
chronic Q-fever.  Those who develop chronic Q-fever need long term antibiotic 
treatment, typically lasting at least 18 months.  While the fatality rate of acute Q-fever is 
less than 2% of hospitalized patients, the fatality rate for chronic Q-fever can be as high 
as 60% (30).  Cattle, sheep, and goats are the primary reservoirs of C. burnetii, with the 
organism excreted in the milk, urine, and feces of infected animals.  Although the most 
common infection route of C. burnetii is inhalation, other infection routes include 
ingestion of raw milk and dairy products made from raw milk.  C. burnetii is extremely 
hardy to harsh physical conditions such as heating and drying.  It is considered to be the 
most heat-resistant, non-spore-forming pathogen found raw milk, making it the pathogen 
of concern for conventional milk pasteurization (29).  Current heat pasteurization 
standards standard for milk are based upon the 6-log10 destruction of C. burnetii in raw 
milk (17, 31, 32). 
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Shiga Toxin-Producing E. coli (STEC) 
 
E. coli is a Gram-negative bacterium commonly found throughout the environment.  
Though most are non-pathogenic and will not cause harm if consumed by humans, some, 
such as Shiga toxin-producing E. coli (STEC), will cause severe gastrointestinal illness 
if consumed (33).  After ingestion of STEC, illness typically follows 3 to 4 days after, 
though incubation times can be as long as 10 days after ingestion before illness is 
evident (33).  Common symptoms of illness include bloody diarrhea, severe abdominal 
cramps, and vomiting.  Though most symptoms subside within seven days, the severity 
of illness can range from mild to extremely severe and even life-threatening (34).  It is 
estimated 265,000 STEC foodborne infections occur each year in the U.S. (33).  The 
most commonly identified STEC in the U.S. regarding foodborne outbreaks is E. coli 
O157:H7, causing more than 63,000 illnesses, 2,100 hospitalizations, and 20 deaths (35).  
Those who become ill with STEC (particularly O157:H7) can develop hemolytic uremic 
syndrome (HUS), a type of kidney failure, hemorrhagic colitis, or thrombotic 
thrombocytopenic purpura, all of which are considered to be life-threatening (36).  
Approximately 25% other persons infected with E. coli O157:H7 are though to develop 
long-term renal sequelae (37).  Foods produced from cattle, such as raw ground beef, 
raw milk, and cheeses made from raw milk, remain the primary vehicles for STEC 
foodborne illnesses, though infection through cross-contamination (such as from not 
properly washing hands) also is a source of concern for STEC (38). 
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Listeria monocytogenes 
 
L. monocytogenes is a Gram-positive bacterium commonly implicated in foodborne 
outbreaks of ready to eat (RTE) or non-processed raw food products.  Listeriosis is 
characterized by fever, muscle aches, and sometimes gastrointestinal distress, similar to 
symptoms of the influenza virus (39).  Listeriosis primarily affects those with a 
weakened immune system, such as newborns and children, pregnant women, the elderly, 
among other immune-compromised individuals (40).  Infection during pregnancy can be 
particularly dangerous, as it can lead to miscarriage, stillbirth, or premature delivery 
(39).  Though listeriosis only causes ~0.02% of foodborne related illnesses, it is a 
significant cause (>25%) of foodborne illness-related deaths (41).  Raw meats, 
vegetables, raw milk and cheeses made with raw milk, and ready to each foods (such as 
deli meat) have been known to cause L. monocytogenes foodborne outbreaks (39).  
Additionally, newborns can be born with listeriosis if their mother consumes 
contaminated food during pregnancy (39). 
 
Salmonella spp. 
 
Salmonella is a Gram-negative bacterium estimated to cause over one million foodborne 
illnesses in the U. S. each year, with 19,000 hospitalizations (~1.9%) and 380 deaths 
(0.038%) associated with these illnesses (42).  Approximately 25% of illnesses in the 
U.S. reported to the CDC are caused by serotype Typhimurium (43).  Illness caused by 
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Salmonella consumption, known as salmonellosis (a form of gastroenteritis), is 
characterized by diarrhea (often bloody), abdominal cramps, fever, nausea, vomiting, 
and headaches (42).  These symptoms typically show up 12 hours to 3 days after 
consumption/exposure and typically last no longer than 7 days (42).  Long-term sequelae 
associated with salmonellosis infection include reactive arthritis, which can last for a few 
months up to many years after illness (42).  This organism has been implicated in 
numerous foodborne outbreaks involving beef, poultry, pork, raw or undercooked eggs, 
and raw milk (44-45). 
 
Ionizing Irradiation as a Food Processing Technology 
 
Gamma, X-Ray, and eBeam Technologies 
 
Irradiation of food products as a non-thermal processing aid has become more prevalent 
in the food industry.  Ionizing irradiation of foods can be achieved primarily through 
gamma rays (such as 
60
Co), x-rays, or electron beam (eBeam) irradiation.  Ionizing 
radiation imparts sufficient energy to produce ionized atoms by removing electrons from 
their orbitals, subsequently damaging microbial DNA by created multiple single and 
double-strand breaks (46-47).  The microbial cells unable to repair their damaged DNA 
die, while other sub-lethally injured microbial cells are unable to replicate.  It is 
important to mention while the desired results of all three methods are the same (namely 
microbial inactivation), there are fundamental differences between them in terms of dose 
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rate, dose penetration, and how the ionizing irradiation is generated, among others (48).  
Gamma irradiation is continuously produced from a radioactive source (cobalt-60 or 
cesium-137), and is often subject to waste as it continuously decays regardless of 
whether it’s treating product.  Additionally, the safety requirements and logistical factors 
(such as facility location) of working with gamma sources, such as dealing with isotope 
procurement and transportation issues, are other things to consider when working with 
this form of irradiation.  However, gamma rays are highly penetrative compared to x-
rays and eBeam, making it more ideal for irradiating denser products, especially at high 
doses.  Electron beam irradiation is generated through the use of commercial electricity.  
X-rays are generated through eBeam technology by converting the high energy electrons 
into photons.  This generation of photons is accomplished by “shooting” the electrons 
through a metal sheet, such as tungsten or tantalum, with an electron beam accelerator.  
Both eBeam and x-ray are considered “on-off” technologies.  Unlike gamma, these 
technologies can be turned off when not in use, saving companies both money and 
energy, and minimizing waste.  Furthermore, eBeam continues to be a prominent method 
for food irradiation, with low equipment costs and relatively short processing times 
being the primary benefits (49).   
 
Food Irradiation Regulations in the United States 
 
The USDA-Animal and Plant Health Inspection Service (USDA-APHIS) approves the 
use of food irradiation for phytosanitary applications for foods imported into the U.S. 
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(≤1.0 kGy).1  Phytosanitary applications of imported foods are necessary to mitigate 
pests that may otherwise pose a risk to U.S. agriculture.  Such pests are dangerous as 
they can feed on and introduce disease to crops, thereby potentially destroying the 
viability of such crops in the U.S.  The use of irradiation technology is beneficial to 
other phytosanitary applications (such as heat or fumigation treatment) as dose 
treatments (≤1.0 kGy) universally affect pests regardless of the commodity being 
irradiated (50-51).  Additionally, irradiation at phytosanitary doses does not affect the 
quality of such produce (48, 52-53).  Phytosanitary irradiation treatment impacts include 
mortality, inability to fly, or sterilization of the pests.  Some produce, such as guavas and 
sweet limes from Mexico, must be processed solely by irradiation before U.S. entry (54).  
The U.S. FDA has approved irradiation for the use of pathogen control in fresh and 
frozen raw poultry and meats (3.0-7.0 kGy) (55).  Irradiation is also approved for the 
treatment of all fresh produce commodities for the extension of shelf life (≤1.0 kGy) 
(55).  The inactivation of microorganisms present in produce is another benefit of 
irradiation, increasing the safety of such foods.  
 
Consumer Acceptability of Irradiated Food Products 
 
Irradiation of foods as a processing technology to increase the shelf life and safety of 
foods is endorsed by a variety of national and international organizations, including the 
                                                 
1
 1 kGy = 100,000 rd 
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FDA, USDA, the International Atomic Energy Agency (IAEA), the Food and 
Agriculture Organization (FAO), and the World Health Organization (WHO), among 
others.  The widespread use of this technology has been hindered by a variety of reasons 
including a lack of consumer acceptance (48).  However, consumers are often not 
informed on the topics of irradiation and the benefits it provides to the foods they 
consume, particularly foods that are minimally processed at home (such as fruits and 
vegetables).  Many consumers erroneously believe the foods become radioactive after 
irradiation or that the technology is used to compensate for unscrupulous food safety 
practices.  Studies have found that once educated, consumers are more likely to accept 
food irradiation as a safe and beneficial processing technology (56).  Other consumer 
acceptance studies regarding food irradiation have found that societal opinions and 
attitudes are likely to heavily influence consumer acceptance, but that education helps 
eliminate consumer misconceptions based on societal opinion (57-58).  Nayga and 
others (59) found that not only did consumer acceptance of irradiated foods increase 
after education, but consumer willingness to purchase irradiated foods also increased.  
The food industry and perhaps key policy makers would likely benefit from better 
understanding the influences of society on consumer opinion to better educate the 
population on possible misconceptions that may arise.  Bruhn (60) suggests consumer 
education messages include information such as microorganisms (harmless and 
pathogenic) are present everywhere, comprehensive yet understandable descriptions of 
foodborne illness, and strategies for preventing such illness.  Acceptance of food 
irradiation technologies is critical for increasing its utilization in the food industry as a 
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processing technology, and it is equally important to educate consumers so they can 
make informed and rational decisions regarding buying and eating irradiated foods. 
 
Irradiation of Dairy Products 
 
It is well-accepted irradiation is an effective technology for increasing public health by 
minimizing (and even eliminating) the presence of pathogens in foods (61).  However, 
other factors of food quality may be affected by this form of processing, such as food 
appearance and sensory qualities.  It is important to consider both safety and quality 
factors when evaluating the effectiveness of such processing.  Though some claim there 
is no need for irradiation of dairy products (and therefore are slow to adopt due to the 
already established effectiveness of thermal pasteurization), there is merit to researching 
the potential of irradiation of dairy products as a cold-pasteurization (non-thermal) 
technology (62).  Many consumers prefer the taste and aroma of raw milk (soft) cheeses 
compared to these cheeses made with pasteurized milk (63).  While the dangers of 
consuming raw milk, and other raw milk-made dairy products are evidenced, many 
consumer still desire the organoleptic properties offered by raw milk dairy products (1, 
64).  Much of current dairy irradiation research revolves determining not only the 
microbiological safety of such foods, but also in determining whether these foods have 
acceptable sensory and other qualities.  Many studies have also looked into utilizing 
irradiation on dairy products made with pasteurized milk as an additional processing aid 
to increase food safety, particular for consumers who are immunocompromised (65-66).  
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Irradiation of dairy products (particularly gamma irradiation) has been well researched, 
but further studies, especially in regards to the electron beam irradiation of milk and 
other dairy foods, would still be beneficial to determine whether such products could be 
marketed as value-added due to its cold-pasteurization processing.  Studies on the 
irradiation of raw milk, particularly with electron beam, are difficult to find.  However, 
numerous studies conducted on dairy products, such as cheese, and dehydrated infant 
formula show promising results that electron beam could be an effective technology for 
the pasteurization of raw milk (67-69).  These studies (outlined below) found irradiation 
effectively reduced pathogen content and increased shelf life of foods without 
significantly affecting sensory properties at pasteurization doses. 
 
Raw Milk 
 
There is minimal literature documenting studies of raw milk irradiation, and none are 
found that discuss it in the context of eBeam irradiation.  Kung and others (70) found 
gamma pasteurization of raw milk at 240,000 roentgens (~2.0 kGy) significantly 
decreased both vitamin A and riboflavin (vitamin B2) content by ~45 and ~25%, 
respectively.  Although milk is not a primary source of vitamin A for the typical diet of a 
consumer from the United States, many consumers receive a significant amount of 
vitamin B2 in their diet from milk (4).  Although specific concentrations of riboflavin 
were not stated in the literature, one could assume, based upon typical levels of 
pasteurized whole milk and considering a 25% destruction of such riboflavin, irradiated 
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milk still remained an excellent source of vitamin B2 and provided more than 20% of the 
current (as of November 2016) recommended daily value (71).  De Oliveira Silva and 
others (68) studied the effects of gamma irradiation on raw milk’s microbiological and 
sensory properties at 0, 1.0, 2.0, and 3.0 kGy.  This study found raw milk had 
significantly less natural microflora when irradiated at 2.0 and 3.0 kGy compared to the 
non-irradiated control (~2.50 and 2.80 log10
 
CFU/mL reductions observed respectively; p 
< 0.05).  Though all members of the sensory panel could differentiate between non-
irradiated and irradiated milk samples, the investigators found that positive attributes, 
such as better taste, were still used to describe irradiated samples up to 2.0 kGy.  Rancid 
odors and flavors were perceived by ~22% of panelists at 3.0 kGy.  The authors 
attributed the formation of rancid odors in the 3.0 kGy irradiated milk due to the 
formation of free radicals affecting the lipid portion of the milk (particularly its fatty 
acids). 
 
Cheese 
 
Literature documents studies of irradiated cheeses made from both raw and thermally 
pasteurized milk.  Kim and others (69) found the natural aerobic microflora of sliced and 
pizza cheeses (made with thermally pasteurized milk) were reduced to non-detectable 
levels after 3.0 kGy for both gamma and eBeam irradiation.  The study also found 
significant reductions of L. monocytogenes and S. aureus (>99.9%) could be achieved at 
a dose of 3.0 kGy, and inoculated pathogens were reduced to non-detectable levels 
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(>99.999% reduction) after 5.0 kGy processing.  Seisa and others (72) did not find 
significant differences in organoleptic properties of thermally pasteurized cheddar 
cheeses after 4.0 kGy gamma irradiation, although they did observe color changes from 
orange (control) to light yellow (irradiated sample), suggesting the annatto coloring in 
cheddar cheese is sensitive to gamma irradiation.  Other studies have shown gamma, x-
ray, and eBeam irradiation technologies improve the safety of raw milk made cheeses by 
significantly decreasing indigenous microflora without significantly affecting flavor and 
other sensory qualities of such products at doses up to 5.0 kGy (67, 73-74). 
 
Other Further-Processed and Related Dairy Products 
 
Significant pathogen reduction in ice creams (inoculated with pathogens such as L. 
monocytogenes, B. abortus, and B. melitensis ) can be achieved with as little as 2.0 kGy 
(75-76).  Badr (77) studied how gamma irradiation at 0, 1.0, 2.0, 3.0, and 4.0 kGy 
affected the microbiological and sensory properties of ice cream.  This study concluded 
that 3.0 kGy significantly reduces inoculated pathogens (S. aureus, L. monocytogenes, 
Salmonella Typhimirium) without adversely affecting sensory attributes such as 
appearance, color, odor, taste, and texture.  Kim and others (78) analyzed gamma 
irradiated ice cream for flavor and other sensory changes at 0, 1.0, 3.0, and 5.0 kGy.  
Their study did not find significant decreases in color, moisture, fat, or flavor quality 
after irradiation.  Some ice cream flavors even showed an increased in acceptability after 
irradiation. 
 21 
 
Current methods of preparation for powdered infant formula does not assure product 
sterility (79).  The primary bacterial pathogen of concern for powdered infant formula is 
Cronobacter sakazakii (formally known as Enterobacter sakazakii) (79).  This pathogen 
is highly resistant to desiccation stress and therefore can survive for long periods of time 
in powdered infant formula once introduced (80).  Many studies have shown that 
ionizing irradiation is an effective processing aid in the inactivation of C. sakazakii in 
dehydrated infant formula.  Powdered infant formula inoculated with 10
6
CFU/g C. 
sakazakii saw approximately a 3-log reduction (D10-value 0.76 ± 0.08 kGy) when 
gamma irradiated at 3.0kGy, and below detection levels were reached at 5.0kGy (81).  
Similar D10-values for C. sakazakii in dehydrated infant formula were also determined 
by Osaili and others (82) and Osaili and others (83) when treatment was applied shortly 
after manufacture of the powdered infant formula.  One key quality of concern when 
producing infant formula is assuring that the nutritional quality remains high, even after 
processing.  A study using eBeam processing up to 25.0kGy showed no significant 
losses of key nutrients nor detrimental effects in dehydrated infant formula, including 
amino acid, fatty acid, and mineral profiles, protein degradation, and lipid oxidation 
(84).  These studies show promise for the application of irradiation technologies for 
dehydrated dairy products, such as powdered milk. 
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Quantitative Microbial Risk Assessment 
 
Microbial foodborne hazards pose a risk to all populations as they are prevalent 
throughout all parts of the world.  QMRA is a valuable tool in identifying the risks 
associated with microbial foodborne hazards (85).  QMRA is especially useful as it can 
systematically relate the performance of one or more intervention methods to determine 
the level of intervention needed to manage food safety risks (86).  Risks can be 
minimized with QMRA analysis to better protect the health of consumers, as the 
capabilities of intervention methods can be quantitatively articulated in terms of the risk 
management necessary to protect public health.  The four primary steps involved in 
QMRA are hazard identification, exposure assessment, risk characterization, and risk 
management. 
 
Primary Steps of QMRA 
 
A problem scenario must first be developed during hazard identification, in which 
situations and problems to be addressed in the hazard analysis are identified.  The 
microbial hazards associated with the chosen scenario are identified and described.  This 
includes providing general information regarding the microbial agent, incubation times, 
and symptoms associated with illness.  
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Exposure assessment involves determining the dose of the microbial hazard of interest 
that people come into contact with.  This aspect of QMRA can be quite complex, as 
many factors involved in microbial exposure need to be taken into account.  The 
information needed to thoroughly conduct the exposure assessment can sometimes be 
difficult (if not impossible) to determine; thus, assumptions often need to be made.  
However, it is important to be extremely thorough and consider every possibility that 
may affect the pathogen exposure.  Even a small change in exposure can have a 
significant impact in the risk characterization (87-88).  A dose response model is also 
identified, in which the risk of response (infection, illness, death, etc.) is estimated given 
a known pathogen dose.
2
  The information gathered from the exposure assessment is 
utilized into the dose response model to predict the risk of response for the chosen 
scenario. 
 
In risk characterization, the information gathered from the exposure assessment is 
incorporated into the dose response model to predict the risk of response for the chosen 
scenario.  Risk characterization is typically accomplished through either the use of 
modeling software, such as R (Wien, Austria), Palisade @Risk (Ithaca, NY), or Oracle® 
Crystal Ball (Redwood City, CA), or through calculating point estimates.  The primary 
difference between the two methods is modeling software can determine a range of risk 
                                                 
2
 Susceptibility of the consumer affects response risk after exposure.  Many studies (such as the one 
presented in this thesis) assume each person (iteration) is equally susceptible to the defined risk. 
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values (including the most likely risk of response in a given distribution, with a defined 
minimum or maximum), while point estimates only determine a single numeric value for 
risk (per calculation). 
 
Based upon the risk quantified from risk characterization, risk management determines 
whether the intervention methods used to control risk are acceptable (determine whether 
the risk assessment goals were met).  Communication of new policies and practices 
arising from QMRA analysis to the food industry and other end-users, key policy 
makers, and the community is an important aspect of risk management.   
 
QMRA Studies on Raw Milk and Raw Milk Cheeses 
 
Numerous risk assessments have been conducted to determine the risk of illness such as 
campylobacteriosis, salmonellosis, and listeriosis from consuming raw milk and raw 
milk-made cheeses.  Some studies simply analyzed illness risks without considering 
possible risk reductions with intervention methods and generated critical data for 
communicating to the public of the health risks due to consuming raw milk and raw milk 
made products (89-92).  Latorre and others (93) determined the risk of illness from 
listeriosis due to raw milk consumption was about 57 – 77 times greater when purchased 
from on-farm and retail stores than when purchased directly from bulk tanks.  The 
authors hypothesized this difference in risk was likely due to time-temperature 
fluctuations when transporting milk, leading to a growth of L. monocytogenes in such 
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products.  Their study suggests handling practices of raw milk greatly affect the 
microbial growth in such products, particularly pertaining to pathogens, similar to what 
would be expected with other temperature-sensitive products.  Other studies, similar to 
the QMRA study presented in this thesis, determined illness risks from consuming 
contaminated raw milk cheeses were significantly less with an intervention treatment 
than without any intervention treatment (94).  Perrin and others (95) explored the effects 
of varying intervention treatments on the risks of contracting HUS from consuming raw 
milk cheeses contaminated with STEC, and found ~76.2 - 98.4% reduction in illness 
risks as a result of these intervention methods.  Studies such as these are beneficial in not 
only communicating the risks of consuming raw milk and related products in a more 
comprehensible manner, but these studies also quantify the benefits of intervention 
methods of raw milk to make is safer in terms of public health. 
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CHAPTER III  
ELECTRON BEAM PASTEURIZATION OF RAW MILK TO REDUCE 
POTENTIAL HEALTH RISKS  
 
Introduction 
 
Raw milk has been implicated in numerous foodborne illnesses and deaths due to 
pathogens in raw milk. Raw milk related outbreaks are estimated to be 150 times more 
likely to occur than from pasteurized milk (23).  The average annual number of 
outbreaks caused by raw milk quadrupled between the years 2007-2012 compared to 
outbreak data from 1993-2006 (24).  This can be attributed to the fact that more states 
are legalizing the sale of raw milk, and this increase in legalization positively correlates 
to the number of raw milk outbreaks.   Heat pasteurization of raw milk by the high 
temperature short time (HTST) method is routinely used by the milk industry to 
inactivate the microbial pathogens that may be present in raw milk. Today, the HTST 
method assures at least a 6.0 log10-reduction of Coxiella burnetii, one of the most heat-
resistant bacteria potentially present in raw milk (2). The HTST milk pasteurization 
technology has been endorsed by a variety of national and international government and 
non-governmental organizations to assure the microbiological safety of milk (19-20, 96).  
However, in recent years, raw cow’s milk has become increasingly popular for a variety 
of reasons including taste, improved nutrient profile, and increased “health benefits” 
from the bacteria present in milk (4, 11). However, there is no significant difference in 
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nutritional content between raw and heat pasteurized milk, and the known health risks 
from consuming raw milk far exceed any possible health benefits (1, 14).  Electron beam 
(eBeam) processing is a non-thermal food processing technology that is proven as an 
effective food pasteurizing technology (46, 97-100).  This FDA-approved technology is 
finding increasing applications for fruits and vegetables, a commodity that is especially 
sensitive to heat treatments (7, 48). The highly energetic electrons in eBeam processing 
are used to inactivate microorganisms by creating multiple double-strand breaks in the 
microbial DNA, preventing the cell from multiplying (47). Quantitative microbial risk 
assessment (QMRA) is a valuable tool for quantifying the risk reduction that can be 
achieved by adopting pathogen intervention technologies. We have previously used 
QMRA methods to quantify the reduction in infection risks associated with the adoption 
of eBeam technology for processing raw oysters, lettuce and spinach and fresh 
strawberries (5-7). QMRA is especially useful as it can systematically relate the 
performance of one or more intervention methods to determine the level of intervention 
needed to manage food safety risks (86).  The QMRA approach at quantifying the 
reduction in infection risks is a powerful risk management and risk communication tool 
(85).  The underlying hypothesis of this study was that eBeam dose at 2.0 kGy is 
effective for non-thermal raw milk pasteurization. The 2.0 kGy dose was chosen based 
upon the pathogen reduction study discussed in this thesis chapter.  The objectives of 
this study focused on determining the reduction of the background microbial populations 
found in raw milk as well as determining the reduction of specific raw milk-associated 
pathogens C. jejuni, L. monocytogenes, S. aureus, and E. coli O157:H7.  We also 
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evaluated the reduction of Coxiella burnetii which is currently used as the benchmark 
organism for heat pasteurization.  Based on empirical pathogen reduction data, we 
quantified the reduction of infection risks associated with C. jejuni, E .coli O157:H7, and 
L. monocytogenes if raw milk was exposed to eBeam at a 2.0 kGy dose. 
 
Materials and Methods 
 
Milk Samples  
 
Raw milk samples were purchased (between ~1.90-3.80 liters) from six different dairy 
farms within the state of Texas. We chose multiple raw milk sources to obtain a wide 
diversity of samples having different levels of background microbial populations. The 
samples were refrigerated (≤ 7.0oC) until analysis, which was completed within 48 hr of 
purchase. A composite raw milk sample was created by combining raw milk samples 
purchased from three separate dairy farms in equal amounts into a sterile 500 mL bottle.  
Two and thirty mL of the composite raw milk sample (for D-10 and bioburden studies, 
respectively) was transferred aseptically into Whirl-Pak bags (Nasco, Fort Atkinson, 
WI). These samples were then exposed to defined eBeam doses and analyzed for their 
microbiological profiles.  
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Electron Beam Irradiation  
 
The eBeam processing was conducted at the National Center for Electron Beam 
Research at Texas A&M University (College Station, TX). Samples were irradiated 
using a 10 MeV, 18 kW Electron Beam Linear Accelerator (LINAC). Alanine 
dosimeters were used to verify the delivered eBeam dose.  Dosimetry was performed 
using alanine dosimeters calibrated to international standards (ISO/ASTM 52628). The 
dosimeters were read using the Bruker e-scan spectrometer (Bruker, Billerica, MA) to 
measure the delivered irradiation dose.  Preliminary dose-mapping studies were 
performed to ensure that the experimental samples received uniform doses with Dose 
Uniformity Ratio (DUR) (Dosemax/Dosemin) values of the experimental samples to as 
close to 1.0 as possible (5-6).  Irradiated samples were packaged thinly (less than 1.0 cm 
thickness) to ensure a uniform dose so that the DUR was approximately 1.0.  A DUR of 
~1.0 indicates the dose received was uniform throughout the sample. The delivery of 
uniform eBeam doses is an important factor when performing irradiation experiments 
and is especially critical when determining the D-10 value to ensure every aliquot of the 
milk sample (and accompanying indigenous and inoculated pathogens) receives the 
same irradiation exposure dose.   
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TABLE 1. Strains used in the pathogen reduction (D-10) study, along with the media used and growth conditions for each 
pathogen before milk inoculation. 
 
 Strains used Media(um) Incubation Time 
and Temperature 
Atmospheric 
condition 
C. jejuni ATCC 33560, PR1-1
1
, PR1-12
1
 Brain, Heart Infusion Broth 
with Preston Campylobacter 
Selective Supplement 
42
o
C, 7 days 6-16% O2, 2-10% 
CO2 
C. burnetii RSA439 Nine Mile phase II
2
 ACCM-2 (101) 37
o
C, 7 days 5% CO2, 2.5% O2 
E. coli O157:H7 ATCC 43889, ATCC 43895, 8624 Tryptic Soy Broth (TSB) 35
o
C, 24 hours Aerobic 
L. monocytogenes ATCC 19115, ATCC 15313, ATCC 43256 TSB with 0.6% yeast extract 30
o
C, 24 hours Aerobic 
S. aureus ATCC 25923, ATCC 29737, ATCC 
33862, two strains isolated from raw milk
3
 
Tryptic Soy Broth 35
o
C, 24 hours Aerobic 
1
Laboratory collection 
2
Provided by J. Samuels laboratory, Texas A&M Health Science Center, Texas A&M University, MS 1359, College Station, 
Texas, USA, 77843-1359 
3
Verified S. aureus using a VITEK Gram-positive identification card (GP card, BioMérieux, Marcy-I’Étoile, France) 
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D-10 Estimations of Specific Pathogens  
 
The D-10 value (the eBeam dose required to achieve 90% reduction (1.0 log10) was 
determined for C. jejuni, L. monocytogenes, E. coli O157:H7, S. aureus, and C. burnetii.  
Multiple strains of these pathogens were grown up in the laboratory under defined 
conditions (Table 1).  The cells were washed and re-suspended in 0.1% peptone.  The 
final titer of these pathogens was estimated be around 10
9
 CFU/ml, verified by an OD600 
≈ 1.0 (BioPhotometer, Eppendorf, Hamburg, Germany).  The strains from the different 
bacterial genera were mixed together individually in equal amounts and inoculated into 
45 ml raw milk samples contained in conical tubes.  Each sample was thoroughly mixed 
and 2 mL aliquots of the inoculated milk samples were placed in sterile Whirlpak bags.  
Only 2 ml of test samples were used to ensure dose uniformity which is critical for D-10 
estimations.  The D-10 value was estimated by subjecting pathogen-inoculated raw milk 
samples to varying eBeam doses between 0.1 and 1.5 kGy.  After eBeam processing, the 
samples were serially diluted in 0.1% peptone water and aliquots plated on specific 
selective and differential media (Table 2) and the numbers of surviving populations were 
estimated.  The numbers (log10 CFU/ml) of the surviving pathogens after exposure to the 
defined eBeam doses were plotted as a function of the measured dose (kGy).  The slope 
of the curve was determined using regression analysis and the negative reciprocal of the 
slope (i.e. D-10 value) was determined for each of the different bacterial pathogens (5-
7).  For C. burnetii analysis, two independent eBeam irradiation trials were performed.  
For C. jejuni and E. coli O157:H7, three independent eBeam irradiation trials were 
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performed.  For L. monocytogenes and S. aureus, four independent eBeam irradiation 
trials were performed.  Three technical replications were completed for each eBeam 
irradiation dose for every trial. 
 
 
 
TABLE 2. Enumeration conditions of specific pathogens in inoculated raw milk after 
eBeam processing. 
 
 Plating Media Incubation Time 
and Temperature 
Atmospheric 
condition 
C. jejuni Campylobacter Blood Free 
Agar with CCDA 
supplement 
42
o
C, 5 days Microaerophilic (6-
16% O2, 2-10% CO2) 
C. burnetii Agarose overlay plates of 
ACCM-2 (36) 
37
o
C, 14 days 5% CO2, 2.5% O2 
E. coli O157:H7 MacConkey Agar with 
Sorbitol  
35
o
C, 36 hours Aerobic 
L. monocytogenes Modified Oxford’s Agar 
with antimicrobic 
supplement  
35
o
C, 48 hours Aerobic 
S. aureus Baird Parker Agar with 
10% Egg Yolk Tellurite  
35
o
C, 48 hours Aerobic 
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Raw Milk Background Bioburden Reduction Studies  
 
Aliquots (30 ml) of the raw milk sample were placed in heat-sealed Whirlpak bags and 
subjected to 1.0 and 2.0 kGy eBeam doses.  Non-irradiated control samples were also 
included in the study.  Growth conditions for aerobic and anaerobic vegetative 
organisms, aerobic and anaerobic sporeformers, and S. aureus, all isolated from raw and 
irradiated milk samples, varied (Table 3).  Before enumerating sporeformers, samples 
were heated to 80
o
C for 12 minutes using a GeneAmp® PCR System 2700 (Applied 
Biosystems, Foster City, Calif.) thermocycler to inactivate any vegetative cells present.  
All platings were performed in triplicate.  After incubation, the colonies were 
enumerated. Coliforms were enumerated using the IDEXX Colilert®-18 assay per the 
manufacturer’s instructions with a slight modification (a 1:100 dilution was made using 
1 mL milk sample in 99 mL 0.1% peptone water for all processed samples) (IDEXX, 
Westbrook, Maine).  After incubation, the yellow and fluorescent wells were counted.  
Fluorescent wells were counted using a hand-held UV light.  The manufacturer-supplied 
MPN table was then used to estimate the MPN/mL of coliforms in each sample.  For 
bioburden reduction studies, two independent eBeam irradiation trials (three replicates 
each) were performed. 
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TABLE 3. Enumeration conditions for select microorganisms isolated from raw milk 
after eBeam processing. 
 
 Media Incubation Time 
and Temperature 
Atmospheric 
condition 
Aerobic Vegetative 
Organisms 
Plate Count Agar 
(PCA) 
35
o
C, 48 hours Aerobic 
Anaerobic Vegetative 
Organisms 
Brucella Blood agar 
with 5% horse blood 
35
o
C, 48 hours Anaerobic (≥13% CO2) 
Aerobic Sporeformers 
PCA + 0.1% soluble 
starch 
35
o
C, 48 hours Aerobic 
Anaerobic 
Sporeformers 
Brucella Blood agar 
with 5% horse blood 
35
o
C, 48 hours Anaerobic (≥13% CO2) 
S. aureus 
Baird Parker Agar 
with 10% Egg Yolk 
Tellurite 
35
o
C, 48 hours Aerobic 
 
 
 
Quantitative Risk Assessment of Infection Risks from Raw and eBeam Pasteurized Milk 
Samples  
 
The infection risks that would arise from exposure to raw milk contaminated with either 
C. jejuni, E. coli O157:H7, or L. monocytogenes and the reduction in infection risks 
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achieved after exposure to eBeam pasteurization (2.0 kGy) were estimated.  Possible 
pathogen titers for L. monocytogenes were based on published literature and assumed to 
follow the Poisson distribution (102-106).  Due to lack of published data, the initial 
pathogen titers for C. jejuni and E. coli O157:H7 were assumed to be 10
3
 CFU/mL and 
also assumed to follow the Poisson distribution.  We assumed a triangular distribution of 
the raw milk serving size between 0 and 711 mL, with 237 mL being the most likely 
serving size (107). The pathogen reduction (D-10) values determined in this study were 
used in determining the expected log reduction of such pathogens when raw milk 
exposed to a 2.0 kGy eBeam dose is consumed.  The infection risks for C. jejuni and L. 
monocytogenes were estimated using the β-Poisson model (equation 1), where Pi is the 
probability of infection, and N is the number of pathogenic bacteria ingested.  Alpha (α) 
is a slope parameter reflecting the dose-response curve, and N50 represents the dose in 
which half of the population is expected to be infected.   
 
Equation 1:   
 
For C. jejuni, α (1.44E-01) and N50 (8.9E+02) were based on the dose-response analysis 
published by Medema and others (108). For L. monocytogenes, α (2.53E-01) and N50 
(2.77E+02) were based on the dose-response analysis published by Haas and others 
(109).  The infection risks for E. coli O157:H7 was estimated using the exponential 
distribution model (equation 2), where Pi is the probability of infection, N is the number 
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of pathogenic bacteria ingested.  K represents the probability of the pathogenic bacteria 
surviving to reach and infect the subject, assuming each pathogen has equal probability.   
 
Equation 2: 
 
For E. coli O157:H7, K (2.18E-04) was based upon dose-response studies conducted by 
Cornick and Helgerson (110), and further dose-response analysis from the Center for 
Advancing Microbial Risk Assessment (111).  The infection risk model for all pathogens 
was simulated with Monte Carlo techniques (10,000 iterations) using Oracle Crystal Ball 
software (V. 11.1.2.4.600, Redwood City, Calif.).  Since the log-reductions for C. jejuni 
and E. coli O157:H7 were too large for risk reduction to be quantified using Crystal Ball 
simulations, a point estimate was calculated to determine the infection risks after eBeam 
processing using the same dose-response formulas identified above. The pathogen titers 
in raw milk per serving used in the point-estimate calculations (pre-eBeam processing) 
were the likely maximum, mean, and median doses consumed before eBeam processing, 
determined from the risk model generated by Crystal Ball.  It was assumed all pathogens 
in the raw milk were infectious and all exposed individuals were susceptible to infection 
from single exposure.  The infection risks were based on illnesses associated with a 
single exposure. 
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Results 
 
Figure 1 shows the reduction in the background aerobic and anaerobic microbial 
populations in the raw milk samples after exposure to 1.0 kGy and 2.0 kGy eBeam dose.  
There were no detectable organisms after eBeam exposure (≥ 3.5 log10-reduction).  The 
background levels of coliforms were reduced to non-detectable levels after even after 1.0 
kGy.  
 
 
FIG 1.  Inactivation of background microbial populations in raw milk after exposure to 
1.0 and 2.0 kGy eBeam doses.  Co represents the starting microbial concentration, and C 
represents the concentration after eBeam treatment. 
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FIG 2.  Inactivation of a) C. burnetii (n=2), b) C. jejuni (n=3), c) E. coli O157:H7 (n=3), 
d) L. monocytogenes (n=4), and e) S. aureus (n=4) in raw milk after exposure to eBeam 
processing.  “n” represents the number of independent experimental replications 
performed.  Each dose point represents three technical replications.  Error bars represent 
standard deviation.  
 
 
 
a) b) 
c) d) 
e) 
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TABLE 4.  Pathogen reduction (D-10) values of key raw milk pathogens in raw milk 
after eBeam processing. 
 
 D-10 Value (kGy) 
C. jejuni 0.071 ±0.009 
C. burnetii 0.151 ±0.028 
E. coli O157:H7 0.062 ±0.008 
L. monocytogenes 0.156 ±0.017 
S. aureus 0.129 ±0.008 
 
 
 
Figure 2 represents the inactivation of the specific pathogens as a function of eBeam 
dose.  Table 4 shows the D-10 values of the selected pathogens investigated.  Table 5 
shows the estimated risk of infection from consuming raw milk contaminated with C. 
jejuni, E. coli O157:H7, or L. monocytogenes as compared to the infection risks if raw 
milk is eBeam pasteurized with 2.0kGy dose.  C. jejuni infection risks without eBeam 
pasteurization ranged between 6 out of 10 persons to as high as 10 out of 10 persons.  
With the use of 2.0 kGy eBeam pasteurization, these risks were reduced to less than 8 x 
10
-18
 persons.  E. coli O157:H7 infection risks without eBeam pasteurization ranged 
between 9 out of 100 persons to as high as 10 out of 10 persons.  With the use of 2.0 
kGy eBeam pasteurization, these risks were reduced to less than 2 x 10
-24
 persons.  L. 
monocytogenes infection risks without eBeam pasteurization ranged between 4 out of 10 
persons to as high as 10 out of 10 persons.  With the use of 2.0 kGy eBeam 
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pasteurization, these risks were reduced to 1 out of 1 trillion persons to 2 out of 1,000 
persons.  To put the risks of infection after eBeam processing into perspective for C. 
jejuni and E. coli O157:H7, it was assumed ~3.0% of the U.S. population consumes raw 
milk on a regular basis (CDC 2007).  Therefore, the average infection risks after milk 
consumption for theses pathogens after eBeam processing was approximately less than 1 
out of 9.735 million persons.  The average infection risk of illness after consuming milk 
contaminated with L. monocytogenes after eBeam processing was approximately 1 out 
of 10 million persons. 
 
Discussion 
 
The dairy industry is growing rapidly in the United States with the demand for dairy 
products such as cheese and butter projected to increase at a faster rate than the US 
population (112).  Milk is a popular dairy product among U.S. consumers, and the and 
Dietary Guidelines for Americans 2015-2020 recommends people consume 2-3 servings 
of dairy products each day (107).  The major finding from this study show that eBeam 
pasteurization of raw milk even at 2.0 kGy dose can significantly reduce most bacterial 
infections associated with raw milk.  Based on the determined pathogen reduction 
values, it can be surmised up to a 12-log reduction of vegetative microorganisms can be 
achieved with 2.0kGy pasteurization.  Thermal pasteurization guarantees a 6.0 log10-
reduction of Coxiella burnetii, the non-sporulating microorganism identified as the most 
resistant to processing methods in raw milk (17). C. burnetii and L. monocytogenes were 
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found to be the most resistant pathogens to eBeam processing, with D-10 values at 
approximately 0.151 and 0.156 kGy, respectively.  Based upon the D-10 values 
determined in this study, more than a 12.0 log10-reduction of C. burnetii is achievable 
with 2.0 kGy.  This reduction translates to more than 2X the reduction achieved with 
HTST, the cornerstone pasteurization technology of the milk industry today. Based on 
the measured D-10 values, a 2.0 kGy eBeam dose can achieve at least a 32.0 log10-
reduction of E. coli O157:H7, a 28.0 log10-reduction of C. jejuni, a 15.0 log10-reduction 
of S. aureus, and more than a 12.0 log10-reduction of C. burnetii and L. monocytogenes.  
Other investigators have also reported on the total aerobic plate counts of 
microorganisms in raw milk, with results ranging from 10
4
-10
6
 CFU/ml (113-115). 
These results are similar to what was determined in this study. This suggests that at 2.0 
kGy, significant inactivation of the background microbial populations is achievable.  The 
USDA Economic Research Service estimates that disease-related infections resulting 
from Campylobacter spp. leads to a loss of $1.93 billion 2013 U.S. dollars, disease-
related infections resulting from E. coli O157:H7 leads to a loss of $271 million 2013 
U.S. dollars, and disease-related infections resulting from L. monocytogenes leads to a 
loss of $2.83 billion 2013 U.S. dollars (116).  This includes costs incurred from time lost 
due to recovery, physician visits and hospitalizations, and mortality.  The QMRA 
performed in this study demonstrates that the infection risks can be significantly reduced 
for the microbial pathogens C. jejuni, E. coli O157:H7, and L. monocytogenes after 
eBeam processing at 2.0 kGy in raw milk.  These reductions in infection risks should 
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TABLE 5.  Potential infection risks from specific pathogens arising from consumption of raw milk with and without eBeam 
pasteurization. 
 
 
Pathogen 
Pathogen 
Concentration in raw 
milk (CFU/serving
1
) 
Infection risks without 
eBeam pasteurization 
Pathogen 
Concentration in 
eBeam pasteurized 
milk
2,3
 (CFU/serving) 
Infection risks 
after eBeam 
pasteurization 
Mean Risk 
reduction  
C. jejuni Mean: 3.16 x 10
8
 
Median: 2.98 x 10
5
 
Mean: 7.80 / 10 persons 
Median: 7.83 / 10 persons 
< 1 Mean: 4.34E-21 
Median: 4.09E-21 
>99.99% 
E. coli O157:H7 Mean: 1.13 x 10
8
 
Median: 2.98 x 10
5
 
Mean: 9.90 / 10 persons 
Median: 9.90 / 10 persons 
< 1 Mean: 2.46E-28 
Median: 6.49E-31 
>99.99% 
 
L. 
monocytogenes 
Mean: 1.15 x 10
7
 
Median: 1.13 x 10
4
 
Mean: 7.94 / 10 persons 
Median: 8.01 / 10 persons 
< 1 Mean: 1.52E-07 
Median: 1.50E-10 
>99.99% 
 
Assumptions: 
1
Serving size: triangular distribution between 0mL – 711mL, with 237mL the most likely 
2
Pasteurization dose: 2.0kGy 
3
C. jejuni 28-log reduction; E.coli O157:H7 32-log reduction; L. monocytogenes 12-log reduction 
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result in significant improvement in public health since the likelihood of consumers 
being exposed to pathogens being negligible after eBeam pasteurization.  Though less 
than 1% milk sold to U.S. consumers is raw milk, the reduction in infection risks can 
still be particularly relevant to foods made with raw milk, such as raw milk made 
cheeses (64).  Raw milk-based cheeses are presently available to consumers in most 
grocery stores in the U.S.   Cheeses made from raw milk were made an exception by the 
FDA in 1987 and are allowed to be shipped and sold in interstate commerce so long as 
the cheese has been aged at least 60 days and is clearly labeled as containing raw milk 
(117).  Although there is a requirement for raw-milk made cheeses to be aged, the risk of 
consuming pathogens from these cheeses is still present, as evidenced by multiple 
outbreaks in which raw-milk made cheeses were implicated to be the cause (35, 40, 43-
44, 118). Previous studies have shown that eBeam processing is a viable technology for 
inactivating pathogens such as L. monocytogenes in a cheese matrix (69, 74, 119).  The 
FDA’s Pasteurized Milk Ordinance (PMO) describes ultra-pasteurization (commercial 
sterilization) as the thermal processing of milk at or above 138
o
C (280
o
F) for at least two 
seconds (20).  Milks processed under these conditions have an extended shelf life under 
refrigerated conditions.  A common problem associated with commercially sterile (UP) 
milk is an undesirable taste (120-121).  Since eBeam technology is a non-thermal 
process, there is the potential for this technology as a substitute for UP milk.  Studies in 
our laboratory indicate that less than 12% of the volatile compounds are different 
between raw milk and eBeam pasteurized milk (data included in following chapter).  
Major advances are occurring in the development of in-line eBeam technology (122).  
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There are also ASTM standards for the dosimetry associated with flowing liquid 
streams.  This study provides experimental evidence that eBeam processing can be used 
as a substitute for heat based pasteurization method for raw milk.  However, use of 
ionizing radiation such as eBeam (or other irradiation technologies) for milk 
pasteurization is not presently permitted by the FDA (123).  There are also, 
unfortunately, a number of regulatory and marketing hurdles preventing the quick 
adoption of this technology by the milk industry (124-125).  Therefore, there should be a 
concerted effort by the raw milk industry stakeholders to seriously explore the use of 
eBeam pasteurization of raw milk. 
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CHAPTER IV  
AROMA AND NUTRIENT PROFILES OF RAW MILK AFTER ELECTRON 
BEAM PASTEURIZATION  
 
Raw Milk and GC-MS Olfactometry Overview 
 
Milk is an excellent dietary source for many nutrients such as calcium, riboflavin, 
vitamin B12, and others (4).  The nutrients found in milk are particularly important in the 
growth and healthy development of children.  Raw milk, though sterile before leaving 
the udder, is host to a vast microflora of bacteria (14, 115).  Bacterial populations are 
able to thrive in raw milk because of its neutral pH, abundance of nutrients, and high 
water activity (0.99) (9-10).  Though some bacterial populations are non-pathogenic, raw 
milk could potentially contain high numbers of infectious organisms such as Salmonella 
spp.,, Listeria spp., and Campylobacter spp., which can lead to illness and possibly death 
(15).  Raw milk has been implicated in numerous foodborne illnesses and deaths due to 
consumption of these and other pathogens (118).  Most milk sold to consumers in the 
U.S. is thermally pasteurized to eliminate pathogens present in the milk, making it safe 
for consumption (19).  Although low heat treatment minimally affects serum proteins 
and some vitamins (such as vitamins B12 and E), it does not significantly contribute to 
nutrient deficiencies based upon U.S. dietary values (126-127).  However, many 
consumers continue to drink raw milk perceiving it to be more “natural” (1).  While 
there may not be an abundance of evidence suggesting the benefits of raw milk, there is 
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overwhelming scientific support regarding the dangers of its consumption (11, 14, 23).  
Electron beam (eBeam) processing is a non-thermal food processing irradiation 
technology proven to be an effective pasteurization technology for foods (5-7, 46, 128). 
The highly energetic electrons, generated through commercial electricity, are used to 
inactivate microorganisms by created single and double-stranded breaks in the microbial 
DNA (47-48). Studies have shown that at low doses of eBeam processing, foods retain 
their original sensory and visual characteristics (52-53, 129-130).  Studies have also 
shown that eBeam processing at varying doses (depending on the food matrix) does not 
significantly affect nutrients present in foods (84, 131-132). The underlying hypothesis 
for this study was that an eBeam dose at 2.0 kGy is not only effective for non-thermal 
raw milk pasteurization but does not significantly breakdown key nutrients found in 
milk, especially when compared to the effects of conventionally pasteurized milk.  This 
study focused on determining concentrations of lactose, calcium, vitamin B2, and 
vitamin B12 before and after eBeam processing.  The amount of lipid oxidation occurring 
due to eBeam pasteurization was also measured.  The molecular weights of casein and 
whey proteins were also analyzed before and after eBeam processing to detect the 
breakdown of these proteins.  Additionally, it was hypothesized that eBeam 
pasteurization will not affect the aroma profile of raw milk. 
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Experimental Design 
 
Sample Acquisition and Preparation   
 
Raw milk samples were purchased from six different dairy farms within the state of 
Texas between October 2015 and August 2016.  Between one-half gallon and one gallon 
of milk was purchased from each farm.  Thermally pasteurized milk samples were 
purchased from local grocery stores in College Station, TX, between October 2015 and 
March 2016.  The samples were stored on ice in coolers during transport to Texas A&M 
University and until analysis. A composite raw milk sample was created by combining 
raw milk samples purchased from three separate dairy farms in equal amounts into a 
sterile 500 mL bottle.  Thirty and one-hundred milliliters of the composite raw milk 
sample was transferred aseptically into Whirl-Pak bags (Nasco, Fort Atkinson, Wis.). 
These samples were then exposed to defined uniform eBeam doses and analyzed for 
specific parameters as described below.  The raw milk and eBeam pasteurized milk 
samples were compared to determine whether eBeam pasteurization affected any of the 
raw milk properties.  
 
eBeam Irradiation Processing  
 
The eBeam processing was conducted at the National Center for Electron Beam 
Research at Texas A&M University (College Station, TX). Samples were irradiated 
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using a 10 MeV, 18 kW Electron Beam Linear Accelerator (LINAC). Alanine 
dosimeters were used to verify the delivered eBeam dose.  Dosimetry was performed 
using alanine dosimeters calibrated to international standards. The dosimeters were read 
using the Bruker e-scan spectrometer (Bruker, Billerica, MA) to measure the delivered 
irradiation dose.  Preliminary dose-mapping studies were performed to ensure that the 
experimental samples received uniform doses with Dose Uniformity Ratio (DUR) 
(Dosemax/Dosemin) values of the experimental samples to be as close to 1.0 as possible 
(5-6).  The samples to be irradiated samples were packaged within thin bags (<1.0 cm 
thickness) and laid flat to ensure a uniform dose so that the DUR was approximately 1.0. 
A DUR of ~1.0 signifies the dose received was uniform throughout the sample.  The 
delivery of uniform eBeam doses is an important factor when performing irradiation 
experiments to ensure every aliquot of the milk sample receives the same irradiation 
exposure dose. 
 
Nutritional Profile Analysis 
 
Lactose Concentrations  
 
The lactose concentrations present in the raw and eBeam processed milk were 
determined using the Lactose Colorimetric/Fluorometric Assay Kit (#K624-100, 
BioVision, Milpitas, CA). Sterile Sensoplate™ 96-well, flat, glass bottom plates were 
used (Greiner bio-one, Stonehouse, UK).  To create a standard curve, the Lactose 
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Standard solution (#K624-100-7) was diluted with assay buffer (#K624-100-1) to 1 
nmol/μL, and 0, 2, 4, 6, 8, and 10 μL of this solution was added into individual wells of 
the 96-well plate.  The volume was adjusted to 50 μL in each well with assay buffer to 
generate 0, 2, 4, 6, 8, and 10 nmol/well of Lactose standard. The eBeam and control raw 
milk samples were diluted by pipetting 50 μL milk into 950 μL ddH2O and mixing well.  
Then, 0.05 μL milk was added to each well, and the volume of each well was adjusted to 
50 μL with lactose assay buffer.  Lactase (2 μL) was added to each standard and sample 
well.  A reaction mix was created per manufacturer’s instructions, and 50 μL reaction 
mix was pipetted into each standard and sample well.  The 96-well plated was covered 
with aluminum foil to protect from light and incubated at 37
o
C for 60 minutes.  The plate 
was measured at 580 nm using a Wallac Victor
2™
 1420 Multilable Counter (Perkin 
Elmer, Waltham, MA).  Lactose concentrations present were calculated using 
Microsoft® Excel per the manufacturer’s instructions. 
 
Casein and Whey Protein Degradation 
 
Casein proteins were extracted as described by Recio and Olieman (133) with some 
modifications to the protocol.  Control and eBeam processed milk samples were brought 
to room temperature. The pH was adjusted to 4.6 using 6 M HCl, stirring constantly.  
Samples were incubated at room temperature for 20 min, and were then centrifuged at 
1800 x g for 20 min.  The supernatant (whey fraction) was aseptically pipetted into a 50 
mL conical tube (VWR, West Chester, PA) and set aside for further purification steps.  
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The remaining pellet (casein) was washed in 20 mL acetate buffer (0.4 M sodium 
acetate, pH 4.6) and centrifuged at 1800 x g for 20 min twice.  The casein pellet was 
then washed with 20 mL dichloromethane to remove lipids and centrifuged at 1800 x g 
for 20 min.  Then, the casein pellet was washed in 20 mL acetate buffer and centrifuged 
at 1800 x g for 20 min.  The casein pellet was resuspended in 15 mL acetate buffer.  
Then, 150 μL of the casein suspension and 450 μL methanol was aseptically pipetted 
into microcentrifuge tubes (VWR, West Chester, PA), vortexed, and then centrifuged at 
13,800 x g for 3 min.  The supernatant was discarded, and the casein pellet was 
resuspended in 200 μL methanol.  The mixture was vortexed and then centrifuged at 
13,800 x g for 2 min.  The supernatant was discarded, and the pellet was allowed to air 
dry for 5 min.  The pellet was then resuspended in 200 μL 10 mM Tris-HCl bufferd (pH 
8.0).  For whey extraction, the supernatant set aside during casein extraction was filtered 
using Durapore® Membrane filter (0.45μM) (Millipore Corporation, Billerica, MA).  
Then, 150 μL of the whey fraction was pipetted into microcentrifuge tubes (VWR, West 
Chester, PA), and 600 μL methanol, 150 μL chloroform, and 450 μL ddH2O was added 
to the whey faction in that order, vortexing in between each addition.  The mixture was 
centrifuged at 13,800 x g for 2 min.  The top layer (above the white disk) was discarded, 
and 450 μL methanol was aseptically pipetted into the mixture, vortexed, and then 
centrifuged at 13,800 x g for 3 min.  The supernatant was discarded, and the whey pellet 
was resuspended in 200 μL methanol.  The whey mixture was vortexed and then 
centrifuged at 13,800 x g for 2 min.  The supernatant was discarded, and the pellet was 
allowed to air dry for 5 min.  The pellet was then resuspended in 50 μL 10 mM Tris-HCl 
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bufferd (pH 8.0).  After extractions, 10 μL of the casein samples and 20 μL of the whey 
samples were pipetted into microcentrifuge tubes  (VWR, West Chester, PA). A 1:1 
dilution was made by adding 2X Laemmli sample buffer (Sigma-Aldrich, St. Louis, 
MO) to each protein sample.  The samples were heated at 95-100
o
C for 5 min, and then 
allowed to cool.  The BenchMark™ Prestained Protein Ladder (#10748-010, Life 
Technologies, Carlsbad, CA) and protein samples were pipetted into the lanes of 
Precise™ Protein Gels 4-20% (#25244, ThermoScientific, Rockford, IL).  The gels were 
run in Tris-HEPES-SDS buffer at 100 to 110 V according to the manufacturer’s 
instructions (ThermoScientific, Rockford, IL).  Once the ladder reached the bottom of 
the gels, the gels were carefully removed from the cassettes and placed in a 0.25% 
Coomassie® Brilliant Blue R-250 (ThermoFisher Scientific, Waltham, MA) staining 
solution for approximately one hour.  After staining, the gels were placed in a destaining 
solution until protein bands were clearly visible (approximately 24 hours).  Protein 
molecular weights were measured using an Odyssey® Imaging System (LI-COR Inc., 
Lincoln, NE) and Odyssey® 2.1 imaging software. 
 
Calcium, and Vitamins B2 & B12 Concentrations   
 
Ebeam processed milk samples were shipped on ice overnight to Eurofins Nutrition 
Analysis Center (Des Moines, IA) for analysis on calcium (AOAC 965.17 / 985.01), 
vitamin B2 (AOAC 970.65), and vitamin B12 (AOAC 952.20).  All analyses were 
performed in a commercial laboratory. 
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Lipid Oxidation   
 
The extent of lipid oxidation in the eBeam processed milk samples as compared to the 
raw untreated samples were determined by measuring the amount of thiobarbituric acid 
reactive substances (TBARS) formed as described by Nagababu and others (134) with 
slight modifications.  For modifications, a 1:1 dilution of the milk sample and butanol 
was made, and 1mL of the dilution mixture was added to 1 mL of 0.67% thiobarbituric 
acid (TBA) in 90% Glacial Acetic Acid.  The sample mixture was placed in a 95-100
o
C 
water bath for 10 min.  After, the sample mixture was read at 526 nm using a Helios 
spectrophotometer (ThermoScientific, Waltham, MA). 
 
Volatile Odorous Compounds 
 
Milk volatiles were evaluated using the Aroma Trax gas chromatograph/mass 
spectrophotometer system with dual sniff ports for characterization of aromatics 
(MicroAnalytics-Aromatrax, Round Rock, Tx).  The milk volatiles in HTST milk 
samples, the raw milk samples and the eBeam treated (1.0 and 2.0 kGy) samples were 
compared. The samples were placed in glass jars (473 mL) with a Teflon lid under the 
metal screw-top to avoid off-aromas.  Then the headspace was collected with a Solid-
Phase Micro-Extraction (SPME) Portable Field Sampler (Supelco 504831, 75 μm 
Carboxen/ polydimethylsiloxane, Sigma-Aldrich, St. Louis, Mo).  The headspace above 
each milk sample in the glass jar was collected for 2 hr for each sample.  Upon 
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completion of collection, the SPME was injected in the injection port of the GC where 
the sample was desorbed at 280°C. The sample was then loaded onto the multi-
dimensional gas chromatograph into the first column (30 m X 0.53 mm ID/ BPX5 (5% 
Phenyl Polysilphenylene-siloxane) X 0.5 μm, SGE Analytical Sciences, Austin, TX) that 
separated compounds based on boiling point.  Through the first column, the temperature 
started at 40°C and increased at a rate of 7°C/min until reaching 260°C. Upon passing 
through the first column, compounds were sent to the second column {(30 m X 0.53 mm 
ID)(BP20- Polyethylene Glycol) X 0.50 μm, SGE Analytical Sciences, Austin, TX}, in 
which compounds were separated based upon polarity.  The gas chromatography column 
then spilt into three different columns at a three-way valve with one going to the mass 
spectrometer (Agilient Technologies 5975 Series MSD, Santa Clara, CA) and two going 
to the two humidified sniff ports with glass nose pieces heated to 115°C.  The sniff ports 
and software for determining flavor and aroma were part of the AromaTrax program 
(MicroAnalytics-Aromatrax, Round Rock, Tx). Only those compounds determined to 
have an aroma were used for analysis.  Any compounds that were not present during an 
aroma event were discarded. 
 
Data Analysis 
 
For lactose, casein, whey, vitamin B2, and lipid oxidation (TBARS) analysis, two 
independent eBeam irradiation trials (with three replicates each) were performed for 
eBeam pasteurized milk samples, and one eBeam trial was performed for calcium and 
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vitamin B12.  For allergen and GC-MS Olfactory (aroma) analysis, one eBeam 
irradiation trial (with two replicates each) was performed.  Analysis of variance 
(ANOVA) and was used to analyze the remaining nutritional data (p<0.05). Newman-
Keuls multiple comparison test (p<0.05) was used to compare the eBeam processing 
treatments against each other when ANOVA determined nutritional concentrations were 
significantly different (0.0 kGy vs. 1.0 kGy, 1.0 kGy vs. 2.0 kGy, and 0.0 kGy vs. 2.0 
kGy). 
 
Results and Discussion 
 
Nutritional Profile Analysis 
 
Lactose 
 
Figure 3 shows lactose concentrations in raw milk before and after eBeam processing at 
0.0, 1.0 and 2.0 kGy.  Mean lactose concentrations for the 0.0 kGy (control), 1.0 kGy, 
and 2.0 kGy doses were 0.74, 0.70, and 0.74 g/fl. oz., respectively.  Mean lactose 
concentrations did not significantly differ between the three eBeam processing 
treatments (p>0.05).   
 
 
 55 
 
 
FIG 3. Scatter plot of lactose concentrations remaining in raw milk (0 kGy) and after 
eBeam processing at 1.0 and 2.0 kGy. The horizontal line represents the median value 
(n=6).  
 
 
 
Our findings correspond to that of previous studies which have reported ionizing 
irradiation does not significantly break down reducing sugars, such as lactose, in foods 
(135-136).  Direct heating of milk can lead to lactose degradation due to the Maillard 
reaction, as lactose (a reducing sugar) will react with lysine residues in milk, present 
mainly in the casein proteins (137).  However, in the case of milk pasteurization (a low 
heat treatment), the Maillard reaction only reaches the early stages and does not 
negatively affect milk’s nutritional value nor does it affect its color or flavor. 
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Casein and Whey Proteins 
 
The molecular weights of two casein and five whey proteins were analyzed after eBeam 
processing of raw milk at doses 0.0, 1.0, and 2.0 kGy (Figures 4-5).  The mean 
molecular weights between the three eBeam processing treatments did not significantly 
differ for any of the analyzed proteins (p>0.05) (Table 1).  Studies have shown thermal 
pasteurization according to U.S. standards can reduce whey proteins by up to ~7-9%, 
while casein proteins remain largely unaffected as the micelles are very stable (126, 138-
140).  Literature largely agrees that proteins in foods remain unaffected when exposed to 
ionizing irradiation at low doses.  Previous studies have reported that eBeam irradiation 
(≤ 4.0 kGy) did not breakdown proteins in shell eggs and liquid eggs yolks (141-142). 
Al-Kahtani and others (143) found that gamma irradiation up to 3.0 kGy minimally 
affected essential and non-essential amino acids found in tilapia and Spanish mackerel.  
They found some amino acids concentrations to remain the same or increase, while some 
(~35% measured amino acids) significantly decreased in concentration.  Matloubi and 
others (144) found that gamma irradiation of baby foods did not significantly affect its 
amino acid profile, an important factor in the nutritional value of proteins in foods.  It is 
not surprising that there was no breakdown in proteins at these doses used in this study.  
Previous studies in our laboratory have shown that the metabolic activity within bacterial 
cells persists even after exposure to 7.0 kGy eBeam dose (145-146).  This indicates that 
the enzymatic proteins are not only structurally intact but also functional even after 
eBeam exposure.  We also noticed that the milk allergens (whey and casein) were not 
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detectable (and presumably unaffected) when exposed to 25.0 kGy using commercial 
detection kits (Reveal 3-D for Total Milk Allergen prod. # 8479, Neogen Corp., Lansing, 
MI).  
 
 
 
FIG 4. Mean molecular weights of α-Casein and β-Casein in raw milk (0 kGy) and after 
eBeam processing at 1.0 and 2.0 kGy (n=6). 
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FIG 5. Mean molecular weights of whey proteins in raw milk (0 kGy) and after eBeam 
processing at 1.0 and 2.0 kGy (n=6).  
 
 
 
Calcium, Vitamin B2, and Vitamin B12 
 
Figure 6 shows calcium concentrations present in raw milk before and after eBeam 
processing at 0.0, 1.0 and 2.0 kGy.  Mean calcium concentrations for each treatment 
were 1.31 , 1.30, and 1.27 mg/g, respectively.  Mean calcium concentrations did not 
significantly differ between the three eBeam processing treatments (p>0.05).  Vitamin 
B2 (riboflavin) concentrations remaining in raw milk after eBeam processing is shown in 
figure 7.  Mean vitamin B2 concentrations for eBeam doses 0.0, 1.0, and 2.0 kGy were 
2.08, 1.61, and 1.42 mg/kg, respectively.  Mean vitamin B2 concentrations did 
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significantly differ between the three eBeam processing treatments (p<0.0001).  Further 
statistical analysis between groups comparing 0.0 vs. 1.0 kGy, 1.0 vs. 2.0 kGy, and 0.0 
vs. 2.0 kGy revealed that all three doses were significantly different (p<0.05).  Figure 8 
shows vitamin B12 concentrations present in raw milk before and after eBeam processing 
at 0.0, 1.0 and 2.0 kGy.  Mean vitamin B12 concentrations for each treatment were 3.734, 
4.009, and 3.848 μg/kg, respectively.  Mean vitamin B12 concentrations did not 
significantly differ between the three eBeam processing treatments (p>0.05).  Studies 
have shown that calcium, along with other minerals, are not degraded at irradiation doses 
commonly employed in food pasteurization (ie., <10.0 kGy) (84, 147-148).  Care must 
be taken when reviewing the literature, as many studies state vitamins are sensitive to  
 
 
 
FIG 6. Scatter plot of calcium concentrations remaining in raw milk (0 kGy) and after 
eBeam processing at 1.0 and 2.0 kGy. The horizontal line represents the median value 
(n=3). 
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FIG 7. Scatter plot of Vitamin B2 (riboflavin) concentrations remaining in raw milk (0 
kGy) and after eBeam processing at 1.0 and 2.0 kGy. The horizontal line represents the 
median value (n=6). 
 
 
 
 
FIG 8. Scatter plot of Vitamin B12 concentrations remaining in raw milk (0 kGy) and 
after eBeam processing at 1.0 and 2.0 kGy.  The horizontal line represents the median 
value (n=3). The data for 0 kGy was based on 2 samples (n=2). 
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irradiation (and thus, were degraded) using doses much higher than that needed to 
pasteurize foods (149).  Studies have shown that gamma irradiation (≤3.0 kGy) does not 
significantly affect vitamins B2 and B12 content in fish (150-151).  Hau and Liew (152) 
found that vitamin B12 was unaffected by gamma irradiation (≤7.0 kGy) of grass prawns.  
Even at sterilization doses for gamma irradiation (28.9-48.7 kGy), no changes in 
vitamins B2 or B12 were observed in animal foods (153).  Our results from this study 
were similar to what’s found in literature, with the exception of the degradation of 
riboflavin when exposed to eBeam processing in milk.  It must be noted though that the 
vitamin concentrations (particularly vitamin B2) cited from the literature were present in 
a solid food matrix when exposed to irradiation.  It may be the case that a solid food 
matrix is better suited for protecting the integrity of vitamin B2 as opposed to an aqueous 
food matrix, such as that of milk.  Water is thought to be able to mobilize catalysts and 
other compounds in foods that may lead to the formation of free radicals, inducing lipid 
oxidation (154-155).  Similar to the findings in our study, Kung and others (70) found 
approximately a 25% loss of vitamin B2 when raw milk was exposed to approximately 
2.0 kGy gamma irradiation.  Furthermore, it must be noted that many food processes, 
including pasteurization of milk, may result in minor losses of vitamins which are 
negligible in terms of necessary dietary intake and do not necessarily contribute to 
vitamin deficiencies in the diet (156-158).  This fact must be kept in mind in regards to 
the potential loss of vitamins and other nutrients in irradiated milks.  Ziegler and Keevil 
(159) found vitamin B2 concentrations in milk to decrease from 9-16% due to thermal 
pasteurization, while Andersson and Öste (160) found vitamin B12 in milk to be 
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unaffected by thermal pasteurization.  After conducting a literature review and 
performing meta-analysis on the compiled literature, MacDonald and others (127) 
determined vitamin B2 concentrations significantly decreased in milk (p<0.05) after 
thermal pasteurization.  Although this study found riboflavin concentrations were 
lowered by 31.57% in raw milk as a consequence of eBeam pasteurization, the residual 
concentration after eBeam processing remains similar to concentrations determined by 
the USDA (71).  Based upon our study, eBeam pasteurized raw milk would still be 
considered an excellent source of vitamin B2 (≥20% of daily value) at a processing dose 
of 2.0 kGy. 
 
Lipid Oxidation 
 
Malondialdehyde (MDA) is a secondary byproduct of lipid oxidation, and its 
concentrations were measured to determine lipid oxidation in raw and eBeam 
pasteurized milk. Concentrations were measured on day 1 (same day as eBeam 
processing) and day 7 to determine concentrations of oxidation in raw milk processed 
with eBeam at 0.0, 1.0, and 2.0 kGy (figures 9-10).  MDA concentrations did not 
significantly differ between the untreated raw milk and the eBeam treated raw milk 
samples on Day 1 (p>0.05).   
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FIG 9. Scatterplot of day 1 MDA concentrations remaining in raw milk (0 kGy) and 
after eBeam processing 1.0 and 2.0 kGy.  The horizontal line represents the median 
value (n=6). The data for 2.0 kGy was based on 4 samples (n=4). 
 
 
 
However, MDA concentrations did significantly differ between eBeam treatments on 
Day 7 (p <0.0001).  Further statistical analysis showed the 0.0 kGy vs. 1.0 kGy 
treatments did not differ significantly, with ~13% increase in MDA concentrations 
(p>0.05).  All other treatment pairs (0.0 kGy vs. 2.0 kGy, 1.0 kGy vs. 2.0 kGy) differed 
significantly in MDA concentrations, showing ~58% and ~39% increases in MDA 
concentrations, respectively (p<0.05).  
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FIG 10. Scatterplot of day 7 MDA concentrations remaining in raw milk (0 kGy) and 
after eBeam processing 1.0 and 2.0 kGy.  The horizontal line represents the median 
value (n=6).  
 
 
 
Although eBeam processed at low doses, it is likely MDA concentrations were 
significantly different between the three processing treatments (with the exception of the 
0.0kGy and 1.0kGy treatments) on day 7 due to the formation free radicals.  As eBeam 
processing is a reducing process and electrons are being introduced in the foods, the high 
fat environment of milk could easily allow for the formation of free radicals 
(particularly, reactions with unsaturated fatty acids), which would in turn, lead to 
secondary oxidative products (161-162).  The carbon-carbon double bonds present on 
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unsaturated fatty acids are likely to be particularly susceptible (163).  Similar results 
were reported in which secondary lipid oxidation products in foods significantly 
increased as a result of electron beam processing, with significant changes observed as 
early as day 0 (164-167).  Additionally, in the case of polymer sterilization, Costa and 
others (168) found hydroperoxides being formed up to 15 days after electron beam 
irradiation.  These studies suggest the formation of such compounds post irradiation is to 
be expected. 
 
Volatile Odorous Compounds 
 
GC-MS olfactory analysis is beneficial in analyzing the odorous (volatile) compounds 
present in foods by trapping the volatiles in a solid phase microextraction fiber (SPME) 
before further analysis.  This technology has the benefit of combining sensory data with 
the identification of the aromatic compound (169). Fifty-three odorous compounds were 
identified in HTST milk and raw milk (untreated) and eBeam treated (1.0 and 2.0 kGy) 
(table 6).  Of these compounds, six (<12%) had at least one treatment significantly differ 
(p<0.05).  Most of the significant odorous compounds (~67%) have an aroma associated 
with their presence, with the exception of 1-octene, which was undetermined, and 
cycloheptane, a non-aromatic compound.  None of the compound classifications stood 
out as more prevalent amongst the significant compounds.  All significant odorous 
compounds were only detected in the eBeam processed milk samples (1.0 and 2.0 kGy), 
suggesting eBeam processing slightly alters the volatile compound profile of raw milk.  
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Linoleic acid is a fatty acid that comprises approximately 60% of milk’s polyunsaturated 
fatty acids, while oleic acid comprises of approximately 100% of milk’s 
monounsaturated fatty acids (71).  Alkenes are typical products of lipid oxidation (170).  
Hexanal, one of the significant aldehydes identified, is a major product of linoleic acid 
oxidation and is assumed to be a reliable indicator of lipid oxidation in food systems 
(171-172).  The presence of significant hexanal in only the eBeam processed samples 
(1.0kGy and 2.0kGy) suggests the possibility of greater oxidation occurring as a result of 
these treatments than compared to raw (0.0 kGy) and store-bought (HTST) milk.   
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TABLE 6.  Odorous compounds present in raw milk after exposure to 1.0 and 2.0 kGy eBeam doses as compared to un-
irradiated (0 kGy) raw milk and heat pasteurized (HTST) milk sample. Each data point reflects the mean from 3 different milk 
sources replicated twice
1
. 
 
Compound 0.0kGy 1.0kGy 2.0kGy HTST
2
 Classification Aroma 
Nonanal 3.845 2.305 2.335 2.39   
p-Xylene 2.215 2.505 0 0   
Benzene, 1,3-dimethyl- 2.135 0 0 0   
1-Decene 0 1.76 1.985 0   
1-Heptene 0 3.975 2.075 0   
2-methyl-2-Propen-1-ol 0
a 
4.2
b 
0
a
 0
a
 Allyl alcohol Pungent, alcohol 
Benzene 0 2.1
 
4.355
 
0   
Benzene, ethyl- 0 2.21 0 0   
Butanal 0 4.83
 
2.39
 
0   
Butanal, 3-methyl- 0 3.95
 
1.925
 
0   
Butanoic acid, methyl ester 0 3.625 2.015 0   
Cycloheptane 0
a
 3.05
b 
3.94
c 
0
a
 Cycloalkane Non-odorous 
Heptane 0 4.34 2.34 0   
Hexanal 0
a
 5.29
b 
5.345
b 
0
a
 Aldehyde Green, grassy 
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TABLE 6 Continued         
Compound 0.0kGy 1.0kGy 2.0kGy HTST
2
 Classification Aroma 
Hexane, 3-ethyl- 0 1.935 0 0   
Pentasiloxane, dodecamethyl- 0 2.09 0 0   
Toluene 0 2.79 2.625 0   
Xylene 0 1.985
 
4.345
 
0   
1-Nonene 0 1.835 0 0   
3-Tetradecene, (Z)- 0 2.12 2.24 0   
Cyclobutanone, 2-ethyl- 0 2.015 4.01 0   
Decanal 0 1.785 2.025 0   
Ethanol, 2-(hexyloxy)- 0 1.915 0 0   
Heptenal 0 1.785 2.025 0   
o-Xylene 0 2.255 0 0   
Octanal 0 2.33 4.81 1.81   
Octanoic acid, ethyl ester 0 1.82 2.505 4.91   
Trans-1-Butyl-2-methylcyclopropane 0 2.28 0 0   
1-Octene 0
a
 0
a
 4.695
b 
0
a
 Alkene Undetermined 
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TABLE 6 Continued         
Compound 0.0kGy 1.0kGy 2.0kGy HTST
2
 Classification Aroma 
3-Dodecen-1-al 0 0 1.79 0   
Butanoic acid, 2-propenyl ester 0 0 2.085 0   
Dimethyldisulfide 0
a
 0
a
 4.165
b 
0
a
 Disulfide Pungent, garlic 
Hexanoic acid, methyl ester 0 0 1.545 0   
N-Heptanal 0 0 2.44 0   
Nonane 0
a
 0
a
 4.62
b 
0
a
 Alkane Sharp, pungent 
Octane 0 0 2.24 0   
Propanoic acid, 2-methyl-,2-ethyl-3-
hydroxyhexyl ester 
0 0 1.65 0 
  
Synephrine 0 0 1.835 0   
Acetic Acid 0 0 1.785 0   
Benzaldehyde 0 0 1.575 0   
Benzene, 1-methyl-4-(1-methylethyl) 0 0 2.285 0   
Benzene, 1,4-dimethyl-2,5-bis(1-
methylethyl)- 
0 0 1.925 0 
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TABLE 6 Continued         
Compound 0.0kGy 1.0kGy 2.0kGy HTST
2
 Classification Aroma 
Benzene, methyl- 0 0 2.68 0   
Cyclobutanemethanol 0 0 1.77 0   
Compound 0.0kGy 1.0kGy 2.0kGy HTST
2
 Classification Aroma 
Decanoic acid, ethyl ester 0 0 2.22 0   
dl-Limonene 0 0 2.355 0   
Eicosanoic acid, methyl ester 0 0 1.545 0   
Hydroxylamine, O-decyl- 0 0 1.595 0   
Naphthalene 0 0 1.815 0   
Hexanoic acid, ethyl ester 0 0 0 1.925   
2-Undecanone 0 0 0 1.625   
3-Oxabicyclononane 0 0 0 1.87   
Dodecanal 0 0 0 1.89   
1
Values in rows that have different superscripts are statistically (p<0.05) different. 
2
HTST: High temperature, short time pasteurization method 
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Conclusions 
 
The purpose of this study was to determine the extent to which eBeam pasteurization of 
raw milk affected the nutrients and aroma profile of raw milk.  All nutrients analyzed, 
with the exception of vitamin B2, were not significantly decreased by eBeam processing.  
Vitamin B2 content was impacted both at the 1.0 and 2.0 kGy doses, with ~22% and 
~32% decreases observed, respectively.  However, milk irradiated at 2.0 kGy still 
remains an excellent source of vitamin B2 according the U.S. dietary recommendations. 
Vitamin B2 fortification can be an option to replace the trace amounts of vitamin B2 lost.  
TBARS and GC-MS olfactory analysis studies both suggest lipid oxidation occurs in 
milk as a result of eBeam pasteurization.  MDA concentrations for milk eBeam 
processed at 2.0 kGy were significantly higher (~58% increase) than the control (0.0 
kGy) 7 days after eBeam processing.  Aldehydes, compounds often formed due to 
oxidation of lipids, were significantly greater in eBeam processed milk samples than the 
control and HTST milk.  Less than 12% of odorous compounds identified in milk were 
determined to significantly differ between at least one treatment.  Further sensory 
analysis would need to be conducted to determine whether humans can detect the subtle 
changes in odorous compounds.  
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CHAPTER V  
CONCLUSIONS AND SUGGESTIONS FOR FUTURE STUDIES  
 
The purpose of the studies presented in this thesis was to determine if key pathogens and 
other indigenous microflora in raw milk could be eliminated with eBeam pasteurization, 
and to determine the extent to which eBeam pasteurization of raw milk affected the 
nutrients and aroma profile of raw milk.   
 
Microbial analysis showed eBeam pasteurization achieves up to a 32.0 log10 theoretical 
reduction of key microbial pathogens at a 2.0 kGy dose, and reduces coliform and 
indigenous microflora counts to below detectable limits.  Significant reductions in 
infection risks from raw milk-associated pathogens is achievable if raw milk is 
pasteurized with eBeam. This major finding translates to the availability of a non-
thermal milk pasteurization technology that can assure public health and wellness for 
consumers, particularly to those who desire to consume raw milk and raw milk based 
products.  
 
None of the nutrients with the exception of vitamin B2, were significantly decreased by 
eBeam processing.  Vitamin B2 content was impacted both at the 1.0 kGy and 2.0 kGy 
doses, with ~22% and ~32% decreases observed, respectively.  However, milk irradiated 
at 2.0 kGy still retains enough vitamin B2 per US dietary guidelines to be considered an 
excellent source of vitamin B2.  Vitamin B2 fortification can be an option to replace the 
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trace amounts of vitamin B2 lost.  Evidence of lipid oxidation was found in both TBARS 
and GC-MS olfactory analysis studies, suggesting that lipid oxidation does occur in milk 
as a result of eBeam pasteurization, similar to findings in other studies (164-167).  
Malondialdehyde concentrations for milk eBeam processed at 2.0 kGy were significantly 
higher (~58% increase) than the control (0.0 kGy) 7 days after eBeam processing.  
Aldehydes, compounds often formed due to oxidation of lipids, were significantly 
greater in eBeam processed milk samples than the control and HTST milk.  Less than 
12% of aromatic compounds identified in milk were determined to significantly differ 
between at least one treatment.  These minor changes in aroma compounds due to 
irradiation suggest that there are minor flavor profile changes occurring.  However, 
sensory analysis would to need to be conducted to determine if humans are able to detect 
these subtle changes and whether these changes negatively affect the overall 
acceptability.  
 
Building on these studies, an important next step would be to conduct sensory panel 
studies to determine consumer acceptability of eBeam pasteurized raw milk, though it is 
highly unlikely IRB approval would be given for human sensory of raw milk.  Studies 
like this would simply need to determine acceptability of irradiated milk without a 
control, which could prove challenging as there is nothing for panelists to compare the 
product to.  Additionally, a study to determine how eBeam pasteurized milk affects the 
quality and other sensory attributes in further processed dairy products (such as soft 
cheeses, yogurt, ice cream, etc.) would be beneficial in determining its usability.  
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Sensory panel studies of these further processed dairy products would also be beneficial.  
Studies like these would allow us to draw conclusions of eBeam pasteurized milk’s 
practicality in the dairy food industry.  Raw milk advocates are unlikely to change their 
opinion of processed milk and drink milk that is not raw.  This fact, along with the 
reality that raw milk represents approximately 1% of all milk sold in the U.S., supports 
the notion that simply selling eBeam pasteurized milk to the public would not be 
financially viable.  However, if eBeam pasteurized milk is able to maintain (and perhaps 
improve) the quality of further processed dairy products, then it would be more likely to 
be widely used in the dairy industry and consumed by its customers.   
 
It would be interesting for a study to focus on developing an in-line eBeam processing 
method for raw milk.  Predicted challenges for this study include temperature control of 
the raw milk, ensuring uniform dose distribution throughout the product, and the 
development of suitable packaging.  Another aspect to consider when processing raw 
milk is it is not homogenized.  Fat will settle at the top of the product when not agitated, 
affecting dose distribution in the product.  In-line eBeam pasteurization studies would 
need to consider solutions for dealing with non-homogenized milk, such as agitation 
before irradiation.  It would also be interesting to study the possibility of homogenizing 
milk before eBeam irradiation.  
 
Finally, an important step for the eBeam pasteurization of raw milk would be developing 
a legal petition to the US FDA to allow for its legal commercial processing use in the 
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food industry.  Studies such as the ones presented in this thesis, along with the suggested 
future studies, would all include critical information to validate the equivalency of 
eBeam pasteurization to conventional thermal pasteurization. 
 
 
 
 
 76 
 
REFERENCES 
 
1. Oliver SP, Boor KJ, Murphy SC, Murinda SE. 2009. Food Safety Hazards 
Associated with Consumption of Raw Milk. Foodborne Pathog Dis 6(7):793-
806. 
2. Oliver SP, Jayarao BM, Almeida RA. 2005. Foodborne Pathogens in Milk and 
the Dairy Farm Environment: Food Safety and Public Health Implications. 
Foodborne Pathog Dis 2:115-129.  
3. Centers for Disease Control and Prevention. 2007. Foodborne Diseases Active 
Surveillance Network (FoodNet): Population Survey Atlas of Exposures, 2006-
2007. Available at: http://www.cdc.gov/foodnet/surveys/foodnetexposure 
atlas0607_508.pdf. Accessed 3 October 2016.  
4. Lucey JA. 2015. Raw Milk Consumption: Risks and Benefits. Nutr Today 
50(4):189-193. 
5. Espinosa AC, Jesudhasan P, Arredondo R, Cepeda M, Mazari-Hiriart M, 
Mena KD, Pillai SD. 2012. Quantifying the Reduction in Potential Health Risks 
by Determining the Sensitivity of Poliovirus Type 1 Chat Strain and Rotavirus 
SA-11 to Electron Beam Irradiation of Iceberg Lettuce and Spinach. Appl 
Environ Microbiol 78(4):988-993. 
6. Praveen C, Dancho BA, Kingsley DH, Calci KR, Meade GK, Mena KD, 
Pillai SD. 2013. Susceptibility of Murine Norovirus and Hepatitis A Virus to 
 77 
 
Electron Beam Irradiation in Oysters and Quantifying the Reduction in Potential 
Infection Risks. Appl Environ Microbiol 79(12):3796-3801. 
7. Shayanfar S, Mena KD, Pillai SD.  2016.  Quantifying the Reduction in 
Potential Infection Risks from non-O157 Shiga Toxin Producing Escherichia coli 
in Strawberries by Low Dose Electron Beam Processing. Food Control, in Press.  
8. LeJeune JT, Rajala-Schultz PJ. 2009. Unpasteurized Milk: A Continued Public 
Health Threat. Clin Infect Dis 48:93–100. 
9. Fernández-Salguero J, Gómez R, Carmona MA. 1993. Water Activity in 
Selected High-Moisture Foods.  J Food Compost Anal 6:364–369. 
10. Walstra P, Geurts TJ, Noomen A, Jellema A, Van Boekel MAJS. 1999. 
Composition, Structure, and Properties, p 3-26. In Dairy Technology: Principles 
of Milk Properties and Processes. Marcel Dekker, New York.  
11. Claeys WL, Cardoen S, Daube G, De Block J, Dewettinck K, Dierick K, De 
Zutter L, Huyghebaert A, Imberechts H, Thiange P, Vandenplas Y, Herman 
L. 2013. Raw or Heated Cow Milk Consumption: Review of Risks and Benefits. 
Food Control 31:251-262. 
12. Axe, J.  2014. Raw Milk Heals Skin, Allergies and Immunity. Available at: 
https://draxe. com/raw-milk-benefits/. Accessed 10 October 2016. 
13. Kresser, C.  2016. Raw Milk Reality: Benefits of Raw Milk. Available at: 
https://chriskresser.com/raw-milk-reality-benefits-of-raw-milk/. Accessed 10 
October 2016. 
 78 
 
14. Jayarao BM, Donaldson SC, Straley BA, Sawant AA, Hegde NV, Brown JL. 
2006. A Survey of Foodborne Pathogens in Bulk Tank Milk and Raw Milk 
Consumption Among farm Families in Pennsylvania. J Dairy Sci 89:2451-2458. 
15. Jayarao BM, Henning DR. 2001. Prevalence of Foodborne Pathogens in Bulk 
Tank Milk. J Dairy Sci 84:2157-2162. 
16. Centers for Disease Control and Prevention. 2015. Legal Status of the Sale of 
Raw Milk, and Outbreaks Linked to Raw Milk, by State, 2007-2012. Available 
at: http://www.cdc.gov/foodsafety/pdfs/legal-status-of-raw-milk-sales-and-outbre 
aks -map-508c.pdf Accessed 12 October 2016. 
17. Cerf O, Condron R.  2006.  Coxiella burnetii and Milk Pasteurization: an Early 
Application of the Precautionary Principle?  Epidemiol Infect 134: 946-951. 
18. American Academy of Pediatrics. 2015. Appendix VI: Prevention of Disease 
from Contaminated Food Products, p. 1004-1007. In: Red Book®: 2015 Report 
of the Committee of Infectious Diseases. 
19. U. S. Food and Drug Administration. 2007. FDA and CDC Remind 
Consumers of the Dangers of Drinking Raw Milk. Available at: 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108
856.htm. Accessed 27 July 2016. 
20. U. S. Food and Drug Administration. 2011. Grade “A” Pasteurized Milk 
Ordinance. Available at: http://www.fda.gov/downloads/Food/GuidanceRegulati 
on/UCM291757.pdf. Accessed: 3 October 2016. 
 79 
 
21. U. S. General Accounting Office. 2000. Food Irradiation: Available Research 
Indicates That Benefits Outweigh Risks. Available at: 
http://www.gao.gov/archive/2000/rc00217.pdf. Accessed 3 November 2016. 
22. Tauxe RV. 2001. Food Safety and Irradiation: Protecting the Public From 
Foodborne Infections. Emerg Infect Dis 7:516-521. 
23. Centers for Disease Control and Prevention. 2014. Raw (Unpasteurized) Milk.  
Available at: http://www.cdc.gov/Features/RawMilk/index.html. Accessed 28 
January 2016. 
24. Mungai EA, Behravesh CB, Gould LH. 2015. Increased Outbreaks Associated 
with Nonpasteurized Milk, United States, 2007-2012.  Emerg Infect Dis 
21(1):119–122. 
25. Allos, BM. 2001. Campylobacter jejuni Infections: Update on Emerging Issues 
and Trends. Clin Infect Dis 32:201-206. 
26. Centers for Disease Control and Prevention. 2014. Campylobacter. Available 
at: https://www.cdc.gov/foodsafety/diseases/campylobacter/. Accessed 15 
October 2016. 
27. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. 1999. Campylobacter jejuni- 
An Emerging Foodborne Pathogen. Emerg Infect Dis 5(1):28-35. 
28. Blaser MJ, Sazie E, Williams LP. 1987. The Influence of Immunity on Raw 
Milk- Associated Campylobacter Infection. JAMA 257(1):43-46. 
29. U. S. Food and Drug Administration. 2012. Bad Bug Book: Foodborne 
Pathogenic Microorganisms and Natural Toxins.  Available at: 
 80 
 
http://www.fda.gov/downloads/Food/FoodborneIllnessContaminants/UCM29762
7.pdf. Accessed 10 December 2015. 
30. Centers for Disease Control and Prevention. 2013. Q Fever. Available at: 
https://www.cdc.gov/qfever/. Accessed 09 December 2015. 
31. Anonymous. 1957. Q Fever and Milk Pasteurization. Public Health Report 
72:947-948. 
32. Enright JB, Sadler WW, Thomas RC. 1957. Pasteurization of Milk Containing 
the Organism of Q Fever. Am J Public Health 47:695-700. 
33. Centers for Disease Control and Prevention. 2015. E. coli (Escherichia coli): 
General Information. Available at: http://www.cdc.gov/ecoli/general/index.html. 
Accessed 15 October 2016.  
34. Guh A, Phan Q, Nelson R, Purviance K, Milardo E, Kinney S, Mshar P, 
Kasacek W, Cartter M. 2010. Outbreak of Escherichia coli O157 Associated 
with Raw Milk, Connecticut, 2008. Clin Infect Dis 51(12):1411-1417. 
35. McCollum JT, Williams NJ, Beam SW, Cosgrove S, Ettestad PJ, Ghosh TS, 
Kimura AC, Nguyen L, Stroika SG, Vogt RL, Watkins AK, Weiss JR, 
Williams IT, Cronquist AB. 2012. Multistate Outbreak of Escherichia coli 
O157:H7 Infections Associated with In-Store Sampling of an Aged Raw-Milk 
Gouda Cheese, 2010. J Food Prot 75(10):1759-1765. 
36. Lye YL, Afsah-Hejri L, Chang WS, Loo YY, Puspanadan S, Kuan CH, Goh 
SG, Shahril N, Rukayadi Y, Khatib A, John YHT, Nishibuchi M, Nakaguchi 
 81 
 
Y, Son R. 2013. Risk of Escherichia coli O157:H7 Transmission Linked to the 
Consumption of Raw Milk. Int Food Res J 20(2):1001-1005. 
37. Denny J, Bhat M, Eckmann K. 2008. Outbreak of Escherichia coli O157:H7 
Associated with Raw Milk Consumption in the Pacific Northwest. Foodborne 
Pathog Dis 5(3):321-328. 
38. Keene WE, Hedberg K, Herriott DE, Hancock DD, McKay RW, Barrett TJ, 
Fleming DW. 1997. A Prolonged Outbreak of Escherichia coli O157:H7 
Infections Caused by Commercially Distributed Raw Milk. J Infect Dis 176:815-
818. 
39. Centers for Disease Control and Prevention. 2007. Listeria (Listeriosis). 
Available at: https://www.cdc.gov/listeria/. Accessed 15 October 2016. 
40. Linnan MJ, Mascola L, Lou XD, Goulet V, May S, Salminen C, Hird DW, 
Yonekura ML, Hayes P, Weaver R, Audurier A, Plikaytis BD, Fannin SL, 
Kleks A, Broome CV. 1988. Epidemic Listeriosis Associated with Mexican-
Style Cheese. New Engl J Med 319(13):823-828. 
41. MacDonald PDM, Whitwam RE, Boggs JD, MacCormack JN, Anderson 
KL, Reardon JW, Saah JR, Graves LM, Hunter SB, Sobel J. 2005. Outbreak 
of Listeriosis Among Mexican Immigrants as a Result of Consumption of Illicitly 
Produced Mexican-Style Cheese. Clin Infect Dis 40:677-682. 
42. Centers for Disease Control and Prevention. 2015. Salmonella. Available at: 
https://www.cdc.gov/salmonella/index.html. Accessed 15 October 2016. 
 82 
 
43. Villar RG, Macek MD, Simons S, Hayes PS, Goldoft MJ, Lewis JH, Rowan 
LL, Hursh D, Patnode M, Mead PS. 1999. Investigation of Multidrug-Resistant 
Salmonella Serotype Typhimurium DT104 Infections Linked to Raw-Milk 
Cheese in Washington State. JAMA 281(9):1811-1816. 
44. Cody SH, Abbott SL, Marfin AA, Schulz B, Wagner P, Robbins K, Mohle-
Boetani JC, Vugia DJ. 1999. Two Outbreaks of Multidrug-Resistant Salmonella 
Serotype Typhimurium DT104 Infections Linked to Raw-Milk Cheese in 
Northern California. JAMA 281(19):1805-1810. 
45. Mazurek J, Salehi E, Propes D, Holt J, Bannerman T, Nicholson LM, 
Bundesen M, Duffy R, Moolenaar RL. 2004. A Multistate Outbreak of 
Salmonella enterica Serotype Typhimurium Infection Linked to Raw Milk 
Consumption- Ohio, 2003. J Food Prot 67(10):2165-2170. 
46. Kundu D, Gill A, Lui C, Goswami N, Holley R. 2014. Use of Low Dose e-
Beam Irradiation to Reduce E. coli O157:H7 non-O157 (VTEC) E. coli and 
Salmonella Viability on Meat Surfaces.  Meat Sci 96:413–418.  
47. Lado BH, Yousef AE. 2002. Alternative Food-Preservation Technologies: 
Efficacy and Mechanisms. Microbes Infect 4:433–440. 
48. Pillai SD, Shayanfar S. 2015. Introduction to Electorn Beam Pasteurization in 
Food Processing, p 3-9. In Pillai SD, Shayanfar S (ed), Electron Beam 
Pasteurization and Complementary Food Processing Technologies. Elsevier 
Limited, Waltham, MA. 
 83 
 
49. Hong Y H, Park JY, Park JH, Chung MS, Kwon KS, Chung K, Won M, 
Song KB. 2008. Inactivation of Enterobacter sakazakii, Bacillus cereus, and 
Salmonella Typhimurium in Powdered Weaning Food by Electron-Beam 
Irradiation. Radiat Phys Chem 77(9):1097–1100. 
50. International Atomic Energy Agency. 2004. Irradiation as a Phytosanitary 
Treatment of Food and Agricultural Commodities. Available at: http://www-
pub.iaea.org/MTCD/publications/PDF/te_1427_web.pdf. Accessed 12 October 
2016. 
51. U.S. Department of Agriculture: Economic Research Service. 2011. 
Irradiation of Produce Imports: Small Inroads, Big Obstacles. Available at: 
http://www.ers.usda.gov/amber-waves/2011/june/irradiation-of-produce-imports/ 
. Accessed 8 November 2016. 
52. Castell-Perez E, Moreno M, Rodriguez O, Moreira RG. 2004. Electron Beam 
Irradiation Treatment of Cantaloupes: Effect on Product Quality. Food Sci Tech 
Int 10(6):383-390. 
53. Moreno MA, Castell-Perez ME, Gomes C, Da Silva PF, Moreira RG. 2007. 
Quality of Electron Beam Irradiation of Blueberries (Vaccinium corymbosum L.) 
at Medium Dose Concentrations (1.0-3.2kGy). LWT 40:1123-1132. 
54. U. S. Department of Agriculture. 2012. Fresh Fruits and Vegetables Manual. 
Available at: https://www.aphis.usda.gov/import_export/plants/manuals/ports/do 
wnloads/fv.pdf. Accessed 8 November 2016. 
 84 
 
55. U. S. Food and Drug Administration. Year unknown. Code of Federal 
Regulations Title 21: 21CFR179.26. Available at: http://www.accessdata.fda.gov 
/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=179.26. Accessed 05 November 2016. 
56. Wilcock A, Pun M, Khanona J, Aung M. 2004. Consumer Attitudes, 
Knowledge and Behavior: a Review of Food Safety Issues. Trends Food Sci 
Technol 15:56-66. 
57. Henson S. 1995. Demand-side Constraints on the Introduction of New Food 
Technologies: The Case of Food Irradiation. Food Policy 20:111-127. 
58. Sapp SG, Harrod WJ. 1990. Consumer Acceptance of Irradiated Food: A Study 
of Symbolic Adoption. J Consum Stud Home Econ 14:133-145. 
59. Nayga RM, Aiew W, Nichols JP. 2004. Information Effects on Consumers’ 
Willingness to Purchase Irradiated Food Products. Rev Agric Econ 27(1):37-48. 
60. Bruhn CM. 1997. Consumer Concerns: Motivating to Action. Emerg Infect Dis 
3(4):511-515. 
61. Osterholm MT, Potter ME. 1997. Irradiation Pasteurization of Solid Foods: 
Taking Food Safety to the Next Level. Emerg Infect Dis 3(4):575-577. 
62. Odueke OB, Farag KW, Baines RN, Chadd SA. 2016. Irradiation Applications 
in Dairy Products: a Review. Food Bioprocess Technol 9:751-767. 
63. Buchin S, Delague V, Duboz G, Berdague JL, Beuvier E, Pochet S, Grappin 
R. 1998. Influence of Pasteurization and Fat Composition of Milk on the Volatile 
Compounds and Flavor Characteristics of a Semi-hard Cheese. J Dairy Sci 
81(12):3097-3108. 
 85 
 
64. Centers for Disease Control and Prevention. 2015. Raw Milk Questions and 
Answers. Available at: http://www.cdc.gov/foodsafety/rawmilk/raw-milk-
questions-and-answers.html Accessed 18 September 2016.  
65. Kamat A, Warke R, Kamat M, Thomas P. 2000. Low-dose Irradiation as a 
Measure to Improve Microbiological Quality of Ice Cream. Int J Food Microbiol 
62:27-35. 
66. Mohácsi-Farkas C. 2016. Food Irradiation: Special Solutions for the Immuno-
Compromised. Radiat Phys Chem 129:58-60. 
67. Aly SA, Farag DE, Galal E. 2012. Effect of Gamma Irradiation on the Quality 
and Safety of Egyptian Karish Cheese. J Am Sci 8(10):761-766. 
68. De Oliveira Silva AC, De Oliveira LAT, De Jesus EFO, Cortez MAS, Alves 
CCC, Monteiro MLG, Conte Junior CA. 2015. Effect of Gamma Irradiation 
on the Bacteriological and Sensory Analysis of Raw Whole Milk Under 
Refrigeration. J Food Process Preserv 39:2404-2411. 
69. Kim HJ, Ham JS, Lee JW, Kim K, Ha SD, Jo C. 2010. Effects of Gamma and 
Electron Beam Irradiation on the Survival of Pathogens Inoculated into Sliced 
and Pizza Cheeses. Radiat Phys Chem 79:731-734. 
70. Kung H, Gaden EL, King CG. 1953. Vitamins and Enzymes in Milk: Effect of 
Gamma-Radiation on Activity. J Agric Food Chem 1(2):142-144. 
71. U. S. Department of Agriculture. 2016. USDA National Nutrient Database for 
Standard Reference 28: 01211, Milk, Whole, 3.25% Milkfat, Without Added 
 86 
 
Vitamin A and Vitamin D. Available from: https://ndb.nal.usda.gov/ndb/. 
Accessed 2016 September 26. 
72. Seisa D, Osthoff G, Hugo C, Hugo A, Bothma C, Van der Merwe J. 2004. 
The Effect of Low-dose Gamma Irradiation and Temperature on the 
Microbiological and Chemical Changes During Ripening of Cheddar Cheese. 
Radiat Phys Chem 69:419-431. 
73. Bougle DL, Stahl V. 1994. Survival of Listeria monocytogenes After Irradiation 
Treatment of Camembert Cheeses Made from Raw Milk. J Food Prot 57(9):811-
813. 
74. Ennahar S, Kuntz F, Strasser A, Bergaentzle M, Hasselmann C, Stahl V. 
1994. Elimination of Listeria monocytogenes in Soft and Red Smear Cheese by 
Irradiation with Low Energy Electrons. Int J Food Sci Technol 29:395-403. 
75. Ganjaroudi FH, Raeisi M, Hajimohammadi B, Zandi H. 2016. Effect of 
Electron Beam Irradiation on Survival of Brucella Spp. in Traditional Ice Cream. 
J Food Process Preserv 40:567-571. 
76. Hashisaka AE, Weagant SD, Dong FM. 1989. Survival of Listeria 
monocytogenes in Mozzarella Cheese and Ice Cream Exposed to Gamma 
Irradiation. J Food Prot 52(7):490-492. 
77. Badr HM. 2012. Improving the Microbial Safety of Ice Cream by Gamma 
Irradiation. Food and Public Health 2(2):40-49. 
78. Kim HJ, Jang A, Ham JS, Jeong SG, Ahn JN, Byun MW, Jo C. 2007. 
Development of Ice Cream with Improved Microbiological Safety and 
 87 
 
Acceptable Organoleptic Quality Using Irradiation. J Anim Sci Technol 
49(4):515-522. 
79. Centers for Disease Control and Prevention. 2016. Cronobacter: Prevention 
and Control. Available at: http://www.cdc.gov/cronobacter/prevention.html. 
Accessed 02 February 2015. 
80. Osaili T, Forsythe S. 2009.  Desiccation Resistance and Persistence of 
Cronobacter Species in Infant Formula. Int J Food Microbiol 136:214-220. 
81. Lee JW, Oh SH, Kim JH, Yook HS, Byun MW. 2006. Gamma Radiation 
Sensitivity of Enterobacter sakazakii in Dehydrated Powdered Infant Formula.  J 
Food Prot 69(6):1434-1437. 
82. Osaili TM, Shaker RR, Abu Al-Hasan AS, Ayyash MM, Martin EM. 2007. 
Inactivation of Enterobacter sakazakii in Infant Milk Formula by Gamma 
Irradiation: Determination of D10-Value.  J Food Sci 72(3):85-88. 
83. Osaili TM, Al-Nabulsi AA, Shaker RR, Ayyash MM, Olaimat AN, Abu Al-
Hasan AS, Kadora KM, Holley RA. 2008. Effects of Extended Dry Storage of 
Powdered Infant Milk Formula on Susceptibility of Enterobacter sakazakii to 
Hot Water and Ionizing Radiation.  J Food Prot 71(5):934-939. 
84. Tesfai A, Beamer SK, Matak KE, Jaczynski J. 2014. Effect of Electron Beam 
on Chemical Changes of Nutrients in Infant Formula. Food Chem 149:208-214. 
85. Duffy G, Cummins E, Nally P, O’Brien S, Butler F. 2006. A Review of 
Quantitative Microbial Risk Assessment in the Management of Escherichia coli 
O157:H7 on Beef.  Meat Sci 74:76–88. 
 88 
 
86. Food and Agriculture Organization of the United Nations. 2007. Principles 
and Guidelines for the Conduct of Microbiological Risk Management. Available 
at: http://www. fao.org/input/download/standards/10741/CXG_063e.pdf. 
Accessed 10 December 2015. 
87. Crotta M, Paterlini F, Rizzi R, Guitian J. 2016. Consumers’ Behavior in 
Quantitative Microbial Risk Assessment for Pathogens in Raw Milk: 
Incorporation of the Likelihood of Consumption as a Function of Storage Time 
and Temperature. J Dairy Sci 99:1029-1038. 
88. Crotta M, Rizzi R, Varisco G, Daminelli P, Cunico EC, Luini M, Graber 
HU, Paterlini F, Guitian J. 2016. Multiple-Strain Approach and Probabilistic 
Modeling of Consumer Habits in Quantitative Microbial Risk Assessment: A 
Quantitative Assessment of Exposure to Staphylococcal Enterotoxin A in Raw 
Milk. J Food Prot 79(3):432-441.   
89. Bemrah N, Sanaa M, Cassin MH, Griffiths MW, Cerf O. 1998. Quantitative 
Risk Assessment of Human Listeriosis from Consumption of Soft Cheese Made 
from Raw Milk. Prev Vet Med 37:129-145. 
90. Giacometti F, Serraino A, Bonilauri P, Ostanello F, Daminelli P, Finazzi G, 
Losio MN, Marchetti G, Liuzzo G, Zanoni RG, Rosmini R. 2012. 
Quantitative Risk Assessment of Verocytotoxin-Producing Escherichia coli 
O157 and Campylobacter jejuni Related to Consumption of Raw Milk in a 
Province in Northern Italy. J Food Prot 75(11):2031-2038. 
 89 
 
91. Giacometti F, Bonilauri P, Albonetti S, Amatiste S, Arrigoni N, Bianchi M, 
Bertasi B, Bilei S, Bolzoni G, Cascone G, Comin D, Daminelli P, Decastelli 
L, Merialdi G, Mioni R, Peli A, Petruzzelli A, Tonucci F, Bonerba E, 
Serraino A. 2015. Quantitative Risk Assessment of Human Salmonellosis and 
Listeriosis Related to the Consumption of Raw Milk in Italy. J Food Prot 
78(1):13-21. 
92. Sanaa M, Coroller L, Cerf O. 2004. Risk Assessment of Listeriosis Linked to 
the Consumption of Two Soft Cheeses Made from Raw Milk: Camembert of 
Normandy and Brie of Meaux. Risk Anal 24(2):389-399. 
93. Latorre AA, Pradhan AK, Van Kessel JAS, Karns JS, Boor KJ, Rice DH, 
Mangione KJ, Gröhn YT, Schukken YH. 2011. Quantitative Risk Assessment 
of Listeriosis Due to Consumption of Raw Milk. J Food Prot 74(8):1268-1281. 
94. Tiwari U, Cummins E, Valero A, Walsh D, Dalmasso M, Jordan K, Duffy G. 
2015. Farm to Fork Quantitative Risk Assessment of Listeria monocytogenes 
Contamination in Raw and Pasteurized Milk Cheese in Ireland. Risk Anal 
35(6):1140-1153. 
95. Perrin F, Tenenhaus-Aziza F, Michel V, Miszczycha S, Bel N, Sanaa M. 
2015. Quantitative Risk Assessment of Haemolytic and Uremic Syndrome 
Linked to O157:H7 and Non-O157:H7 Shiga-Toxin Producing Escherichia coli 
Strains in Raw Milk Soft Cheeses. Risk Anal 35(1):109-128. 
 90 
 
96. U. S. Food and Drug Administration. 2011. Questions and Answers: Raw 
Milk. Available at: http://www.fda.gov/food/foodborneillnesscontaminants/buy 
storeservesafefood/ucm12206 2.htm. Accessed 27 July 2016. 
97. Cabeza MC, Cambero MI, Núñez M, Medina M, de la Hoz L, Ordóñez JA. 
2010. Lack of Growth of Listeria monocytogenes and Staphylococcus aureus in 
Temperature Abuse of E-beam Treated Ready-to-Eat (RTE) Cooked Ham. Food 
Microbiol 27:777–782.  
98. Han J, Gomes-Feitosa CL, Castell-Perez E, Moreira RG, Silva PF. 2004. 
Quality of Packaged Romaine Lettuce Hearts Exposed to Low-Dose Electron 
Beam Irradiation.  LWT 37:705–715.  
99. Lewis SJ, Velasquez A, Cuppett SL, McKee SR. 2002. Effect of Electron 
Beam Irradiation on Poultry Meat Safety and Quality.  Poult Sci 81(6):896–903. 
100. Su YC, Duan J, Morissey MT. 2004. Electron Beam Irradiation for Reducing 
Listeria monocytogenes Contamination of Cold-Smoked Salmon.  J Aquat Food 
Prod Tech 13(1):3–11. 
101. Omsland A, Beare PA, Hill J, Cockrell DC, Howe D, Hansen B, Samuel JE, 
Heinzen RA. 2011. Isolation from Animal Tissue and Genetic Transformation of 
Coxiella burnetii are Facilitated by an Improved Axenic Growth Medium. Appl 
Environ Microbiol 77(11): 3720-3725. 
102. Haas CN, Thayyar-Madabusi A, Rose JB, Gerba CP. 1999. Development and 
Validation of Dose-Response Relationship for Listeria monocytogenes. Quant 
Microbiol 1(1):89-102. 
 91 
 
103. Meyer-Broseta S, Diot A, Bastain S, Rivière J, Cerf O. 2003. Estimation of 
Low Bacterial Concentration: Listeria monocytogenes in Raw Milk.  Int J Food 
Microbiol 80:1–15. 
104. Ruusunen M, Salonen M, Pulkkinen H, Huuskonen M, Hellström S, Revez 
J, Hänninen M, Fredriksson-Ahomaa M, Lindström M. 2013. Pathogenic 
Bacteria in Finnish Bulk Tank Milk. Foodborne Pathog Dis 10(2):99-106. 
105. Van Kessel JS, Karns JS, Gorski L, McCluskey BJ, Perdue ML. 2004. 
Prevalence of Salmonellae, Listeria monocytogenes, and Fecal Coliforms in Bulk 
Tank Milk on US Dairies. J Dairy Sci 87:2822–2830.  
106. Waak E, Wilhelm T, Danielsson-Tham M. 2002. Prevalence and 
Fingerprinting of Listeria monocytogenes Strains Isolated from Raw Whole Milk 
in Farm Bulk Tanks and in Dairy Plant Receiving Tanks. Appl Environ Microbiol 
68(7):3366–3370. 
107. U.S. Department of Health and Human Services and U.S. Department of 
Agriculture. 2015. 2015 – 2020 Dietary Guidelines for Americans: 8th Edition. 
Available at: https://health.gov/dietaryguidelines /2015/. Accessed 10 November 
2016. 
108. Medema GJ, Teunis PFM, Havelaar AH, Haas CN. 1996. Assessment of the 
Dose-response Relationship of Campylobacter jejuni. Int J Food Microbiol 
30:101-111. 
109. Haas CN, Rose JB, Gerba CP. 1999. Quantitative Microbial Risk Assessment. 
John Wiley & Sons, New York, NY. 
 92 
 
110. Cornick NA, Helgerson AF. 2004. Transmission and Infectious Dose of 
Escherichia coli O157:H7 in Swine. Appl Environ Microbiol 70(9):5331-5335. 
111. Center for Advancing Microbial Risk Assessment. 2016.  Table of 
Recommended Best Fit Parameters. Available at: http://qmrawiki.canr.msu.edu 
/index.php?title=Table_of_Recommended_Best-Fit_Parameters. Accessed 8 
August 2016.  
112. U. S. Department of Agriculture. 2016. USDA Long-Term Projections “U. S. 
Livestock”. Available at: http://www.ers.usda.gov/publications/oce-usda-
agricultural-projections/oce-2016-1.aspx. Accessed 13 September 2016. 
113. Boor KJ, Brown DP, Murphy SC, Kozlowski SM, Bandler DK. 1998. Our 
Industry Today: Microbiological and Chemical Quality of Raw Milk in New York 
State.  J Dairy Sci 81:1743-1748. 
114. Chye FY, Abdullah A, Ayob MK.  2004.  Bacteriological Quality and Safety of 
Raw Milk in Malaysia.  Food Microbiol 21:535-541. 
115. Desmasures N, Bazin F, Guéguen M. 1997.  Microbiological Composition of 
Raw Milk from Selected Farms in the Camembert Region of Normandy. J Appl 
Microbiol 83:53-58. 
116. U.S. Department of Agriculture: Economic Research Service. 2013. Cost 
Estimates of Foodborne Illnesses. Available at: http://www.ers.usda.gov/data-
products/cost-estimates-of-foodborne-illnesses.asp x. Accessed 20 September 
2016. 
 93 
 
117. U. S. Food and Drug Administration. 1987. Code of Federal Regulations Title 
21: 21CFR1240.61. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfd 
ocs/cfcfr/cfrsearch.cfm?fr=1240.61. Accessed 20 September 2016. 
118. Langer AJ, Ayers T, Grass J, Lynch M, Angulo FJ, Mahon BE. 2012. 
Nonpasteurized Dairy Products, Disease Outbreaks, and state Laws-United States, 
1993-2006. Emerg. Infect Dis 18(3):385-391. 
119. Velasco R, Ordóñez JA, Cambero MI, Cabeza MC. 2015. Use of E-beam 
Radiation to Eliminate Listeria monocytogenes from Surface Mold Cheese. Int 
Microbiol 18:33-40. 
120. Clare DA, Bang WS, Cartwright G, Drake MA, Coronel P, Simunovic J. 
2005. Comparison of Sensory, Microbiological, and Biochemical Parameters of 
Microwave Versus Indirect UHT Fluid Skim Milk During Storage. J Dairy Sci 
88(12):4172-4182. 
121. Simon M, Hansen AP. 2001. Effect of Various Dairy Packaging Materials on 
the Shelf Life and Flavor of Ultrapasteurized Milk. J Dairy Sci 84(4):784-791. 
122. Comet Group. Electron Beam Revolution. Available at: http://comet-
ebeam.com/. Accessed 13 October 2016. 
123. Arvanitoyannis IS, Tserkezou P. 2010. Legislation on Food Irradiation: 
European Union, United States, Canada, and Australia, p 3-20. In Arvanitoyannis 
IS (ed), Irradiation of Food Commodities: Techniques, Applications, Detection, 
Legislation, Safety, and Consumer Opinion, 1st Ed. Elsevier, Burlington, MA.  
 94 
 
124. Ledenbach LH, Marshall RT. 2009. Microbiological Spoilage of Dairy 
Products, p 41-67. In Sperber WH, Doyle MP (ed), Compendium of the 
Microbiological Spoilage of Foods and Beverages. Springer Science+Business 
Media, New York, NY.    
125. National Advisory Committee on Microbiological Criteria for Foods. 2006. 
Requisite Scientific Parameters for Establishing the Equivalence of Alternative 
Methods of Pasteurization. J Food Prot 69(5):1190-1216. 
126. Grappin R, Beuvier E. 1997. Review: Possible Implications of Milk 
Pasteurization on the Manufacture and Sensory Quality of Ripened Cheese. Int 
Dairy J 7:751-761. 
127. MacDonald LE, Brett J, Kelton D, Majowicz SE, Snedeker K, Sargeant JM. 
2011. A Systematic Review and Meta-Analysis of the Effects of Pasteurization on 
Milk Vitamins, and Evidence for Raw Milk Consumption and Other Health-
Related Outcomes. J Food Prot 74(11):1814-1832. 
128. Schmidt HM, Palekar MP, Maxim JE, Castillo A. 2006. Improving the 
Microbiological Quality and Safety of Fresh-Cut Tomatoes by Low-Dose 
Electron Beam Irradiation. J Food Prot 69(3):575-581. 
129. Gomes C, Da Silva P, Chimbombi E, Kim J, Castell-Perez E, Moreira RG. 
2008. Electron-beam Irradiation of Fresh Broccoli Heads (Brassica oleracea L. 
italic). LWT – Food Sci Tech 41:1828-1833. 
130. Park JG, Yoon Y, Park JN, Han IJ, Song BS, Kim JH, Kim WG, Hwang HJ, 
Han SB, Lee JW. 2010. Effects of Gamma Irradiation and Electron Beam 
 95 
 
Irradiation on Quality, Sensory, and Bacterial Populations in Beef Sausage 
Patties. Meat Sci 85:368-372. 
131. Arvanitoyannis IS, Tziatzios G. 2010. Proteins. In: Arvanitoyannis IS, editor. 
Irradiation of Food Commodities: Techniques, Applications, Detection, 
Legislation, Safety, and Consumer Opinion. 1st Edition. Burlington, MA: 
Elsevier. p 367-447. 
132. Carocho M, Barreira JCM, Antonio AL, Bento A, Kaluska I, Rerreira 
ICFR. 2012. Effects of Electron-Beam Radiation on Nutritional Parameters of 
Portuguese Chestnuts (Castanea sativa Mill.). J Agric Food Chem 60:7754-7760. 
133. Recio I, Olieman C. 1996. Determination of Denatured Serum Proteins in the 
Casein Fraction of Heat-treatment Milk by Capillary Zone Electrophoresis. 
Electrophoresis 17:1228-1233. 
134. Nagababu E, Rifkind JM, Boindala S, Nakka L. 2010. Assessment of 
Antioxidant Activity of Eugenol In Vitro and In Vivo. In: Uppu RM, Murthy SN, 
Pryor WA, Parinandi, NL, editors. Free Radicals and Antioxidant Protocols. 2
nd
 
Ed. New York: Humana Press. p 165-180. 
135. Burton WG, Horne T, Powell DB. 1959. The Effect of Gamma-irradiation 
Upon the Sugar Content of Potatoes. Eur Potato J 2(2):105-116. 
136. Lee JW, Kim JK, Srinivasan P, Choi J, Kim JH, Han SB, Kim D, Byun 
MW. 2009. Effect of Gamma Irradiation on Microbial Analysis, Antioxidant 
Activity, Sugar Content and Color of Ready-to-Use Tamarind Juice During 
Storage. LWT – Food Sci Tech 42:101-105. 
 96 
 
137. Van Boekel MAJS. 1998. Effect of Heating on Maillard Reactions in Milk. 
Food Chem 62(4):403-414. 
138. Douglas FW, Greenberg R, Farrell HM, Edmondson LF. 1981. Effects of 
Ultra-High-Temperature Pasteurization on Milk Proteins. J Agric Food Chem 
29:11-15. 
139. Rynne NM, Beresford TP, Kelly AL, Guinee TP. 2004. Effect of Milk 
Pasteurization Temperature and In Situ Whey Protein Denaturation on the 
Composition, Texture and Heat-induced Functionality of Half-fat Cheddar 
Cheese. Int Dairy J 14:989-1001. 
140. Walstra P. 1990. On the Stability of Casein Micelles. J Dairy Sci 73(8):1965-
1979. 
141. Huang S, Herald TJ, Mueller DD. 1997. Effect of Electorn Beam Irradiation on 
Physical, Physicochemical, and Functional Properties of Liquid Egg Yolk During 
Frozen Storage. Poult Sci 76:1607-1615. 
142. Wong PYY, Kitts DD. 2002. Physicochemical and Functional Properties of 
Shell Eggs Following Electron Beam Irradiation. J Sci Food Agric 83:44-52. 
143. Al-Kahtani HA, Abu-Tarboush HM, Atia M, Bajaber AS, Ahmed MA, El-
Mojaddidi MA. 1998. Amino Acid and Protein Changes in Tilapia and Spanish 
Mackerel After Irradiation and Storage. Radiat Phys Chem 51(1):107-114. 
144. Matloubi H, Aflaki F, Hadjiezadegan M. 2004. Effect of γ-irradiation on 
Amino Acids Content of Baby Food Proteins. J Food Compost Anal 17:133-139. 
 97 
 
145. Hieke, C. 2015. Investigating the Inactivation, Physiological Characteristics, and 
Transcriptomic Responses of Bacteria Exposed to Ionizing Radiation.  PhD 
dissertation. Texas A&M University, College Station, TX. 
146. Praveen C. 2014. PhD dissertation. Texas A&M University, College Station, 
TX. 
147. Bhat R, Sridhar KR. 2008. Nutritional Quality Evaluation of Electron Beam-
Irradiated Lotus (Nelumbo nucifera) Seeds. Food Chem 107:174-184. 
148. Bhat R, Sridhar KR, Young C, Bhagwath AA, Ganesh S. 2008. Composition 
and Functional Properties of Raw and Electron Beam-irradiated Mucuna pruriens 
Seeds. Int J Food Sci Tech 43:1338-1351. 
149. Diehl JF. 1992. Food irradiation: Is It an Alternative to Chemical Preservatives? 
Food Addit Contam 9(5):409-416. 
150. Al-Kahtani HA, Abu-Tarboush HM, Bajaber AS, Atia M, Abou-Arab AA, 
El-Mojaddidi MA. 1996. Chemical Changes After Irradiation and Post-
Irradiation Storage in Tilapia and Spanish Mackerel. J Food Sci 61(4):729-733. 
151. Liu M, Chen R, Tsai M, Yang J. 1991. Effect of Gamma Irradiation on the 
Keeping Quality and Nutrients of Tilapia (Oreochromis mossambicus) and Silver 
Carp (Hypophthalmichthys molitrix) Stored at 1
o
C. J Sci Food Agric 57:555-563. 
152. Hau LB, Liew MS. 1993. Effects of γ-Irradiation and Cooking on Vitamins B6 
and B12 in Grass Prawns. Radiat Phys Chem 42:297-300. 
 98 
 
153. Caulfield CD, Cassidy JP, Kelly JP. 2008. Effects of Gamma Irradiation and 
Pasteurization on the Nutritive Composition on Commercially Available Animal 
Diets. Journal Am Assoc Lab Anim Sci 47(6):61-66. 
154. Kamal-Eldin A, Appelqvisr L. 1996. The Chemistry and Antioxidant Properties 
of Tocopherols and Tocotrienols. Lipids 31(7):671-701. 
155. Labuza TP, Dugan LR. 1971. Kinetics of Lipid Oxidation in Foods. CRC Crit 
Rev Food Tech 2:355-405. 
156. Bender AE. 1966. Nutritional Effects of Food Processing. J Food Tech 1:261-
289. 
157. Kava R. 2000. Food Irradiation and Vitamin Loss. Int J Infect Dis 4(4):232. 
158. Reddy MB, Love M. 1999. The Impact of Food Processing on the Nutritional 
Quality of Vitamins and Minerals. In: Jackson LS, Knize MG, Morgan JN, 
editors. Impact of Processing on Food Safety. V. 459. New York: Spring 
Science+Business Media. p 99-106. 
159. Ziegler JA, Keevil NB. 1944. Photochemical Destruction of Riboflavin in Milk 
and Losses During Processing. J Biol Chem 155:605-606. 
160. Andersson I, Öste R. 1994. Nutritional Quality of Pasteurized Milk, Vitamin 
B12, Folate and Ascorbic Acid Content During Storage. Int Dairy J 4:161-172. 
161. Nam KC, Ahn DU. 2003. Use of Antioxidants to Reduce Lipid Oxidation and 
Off-odor Volatile of Irradiated Pork Homogenates and Patties.  Meat Sci 63:1-8. 
162. Shahidi F, Zhong Y. 2010. Lipid Oxidation and Improving the Oxidative 
Stability. Chem Soc Rev 39:4067-4079. 
 99 
 
163. Brewer MS. 2009. Irradiation Effects on Meat Flavor: A review. Meat Sci 81:1-
14 
164. Du M, Ahn DU, Nam KC, Sell JL. 2001. Volatile Profiles and Lipid Oxidation 
of Irradiated Cooked Chicken Meat from Laying Hens Fed Diets Containing 
Conjugated Linoleic Acid. Poult Sci 80:235-241. 
165. Rababah T, Hettiarachchy N, Horax R, Eswaranandam S, Mauromoustakos 
A, Dickson J, Niebuhr S. 2004. Effect of Electron Beam Irradiation and Storage 
at 5
o
C on Thiobarbituric Acid Reactive Substances and Carbonyl Contents in 
Chicken Breast Meat Infused with Antioxidants and Selected Plant Extracts. J 
Agric Food Chem 52:8236-8241. 
166. Rababah T, Hettiarachchy NS, Horax R, Cho MJ, Davis B, Dickson J. 2006. 
Thiobarbituric Acid Reactive Substances and Volatile Compounds in Chicken 
Breast Meat Infused with Plant Extracts and Subjected to Electron Beam 
Irradiation. Poult Sci 85:1107-1113. 
167. Zhu MJ, Mendonca A, Min B, Lee EJ, Nam KC, Park K, Du M, Ismail HA, 
Ahn DU. 2004. Effects of Electron Beam Irradiation and Antimicrobials on the 
Volatiles, Color, and Texture of Ready-to-eat Turkey Breast Roll. J Food Sci 
69(5):382-387. 
168. Costa L, Carpentieri I, Bracco P. 2008. Post Electron-beam Irradiation 
Oxidation of Orthopaedic UHMWPE. Polym Degrad Stab 93:1695-1703. 
169. Rabaud NE, Ebeler SE, Ashbaugh LL, Flocchini RG. 2002. The Application 
of Thermal Desorption GC/MS with Simultaneous Olfactory Evaluation for the 
 100 
 
Characterization and Quantification of Odor Compounds from a Dairy. J Agric 
Food Chem 50:5139-5145. 
170. Smith TJ, Campbell RE, Jo Y, Drake MA. 2016. Flavor and Stability of Milk 
Proteins. J Dairy Sci 99:4325-4346. 
171. Larick DK, Turner BE, Schoenherr WD, Coffey MT, Pilkington DH. 1991. 
Volatile Compound Content and Fatty Acid Composition of Pork as Influenced 
by Linoleic Acid Content of the Diet. J Anim Sci 70:1397-1403. 
172. Liu HF, Booren AM, Gray JI, Crackel RL. 1992. Antioxidant Efficacy of 
Oleoresin Rosemary and Sodium Tripolyphosphate in Restructured Pork Steaks. J 
Food Sci 57(4):803-806. 
 
 
 
 101 
 
APPENDIX 
 
TABLE A-1.  Foodborne outbreaks associated with raw milk or raw milk-made products in the United States: 1992-2016. 
 
Year State(s) Contaminating Pathogen No. Illnesses No. Hospitalizations No. deaths Food Vehicle Reference(s) 
2016 CO Campylobacter spp. 20 0 0 raw milk Marler blog 
2016 CA E. coli O157:H7 8 NR
1,2 
0 raw milk Marler blog 
2014 UT Salmonella Newport 2 0 0 raw milk CDC 2016 
2014 PA Campylobacter spp. 2 0 0 raw milk CDC 2016 
2014 MN C. jejuni 9 2 0 raw milk CDC 2016 
2014 MI E. coli O157:H7 2 0 0 raw milk CDC 2016 
2014 NY C. jejuni 8 0 0 raw milk CDC 2016 
2014 CA, FL L. monocytogenes 2 2 1 raw milk CDC 2016 
2014 UT C. jejuni 99 10 1 raw milk Davis and others 
2016 
2012 OR E. coli O157:H7 16 4 0 raw milk CDC 2016 
2012 CA C. jejuni 33 2 0 raw milk CDC 2016 
2012 CO E. coli 0111 2 0 0 raw milk CDC 2016 
2011 SC C. jejuni 23 1 0 raw milk CDC 2016 
2011 MI Campylobacter spp. 2 0 0 raw milk CDC 2016 
2011 NY C. jejuni 4 0 0 raw milk CDC 2016 
2011 NY C. jejuni 3 0 0 raw milk CDC 2016 
2011 NY C. jejuni 13 0 0 raw milk CDC 2016 
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2011  CA E. coli O157:H7 5 3 0 raw milk CDC 2016 
2010 CA, NV, AZ, 
CO, NM 
E. coli O157:H7 41 18 NR gouda cheese
3
 McCollum and 
others 2012 
2010 NY C. jejuni 20 1 0 raw milk CDC 2016 
2010 IL C. jejuni 2 0 0 raw milk CDC 2016 
2008 CT E. coli O157:H7 14 5
4
 NR raw milk Guh and others 
2010 
2008 TN C. jejuni 4 0 0 raw milk CDC 2016 
2008 CT E. coli O157:NM 14 5 0 raw milk CDC 2016 
2008 MA C. jejuni 8 0 0 raw milk CDC 2016 
2008 MN Campylobacter spp. 2 0 0 raw milk CDC 2016 
2008 PA C. jejuni 65 1 0 raw milk CDC 2016 
2008 VT E. coli O157:H7 6 3 0 raw milk CDC 2016 
2008 UT C. jejuni 4 0 0 raw milk CDC 2016 
2008 CA C. jejuni 16 NR NR raw milk CDC 2016 
2008 ND C. jejuni 3 0 0 raw milk CDC 2016 
2007 PA Salmonella Typhimurium 29 2 NR raw milk, soft 
cheese 
Lind and others, 
2007 
2007 SC C. jejuni, S. enterica 11 4 0 raw milk CDC 2016 
2007 KS C. jejuni 16 0 0 cheddar cheese CDC 2016 
2007 WA C. jejuni 18 0 0 raw milk CDC 2016 
2007 PA Salmonella Typhimurium 4 0 0 raw milk made 
cheese 
CDC 2016 
2007 CA Campylobacter spp. 11 0 0 raw milk CDC 2016 
2006 VA C. jejuni 9 0 0 raw milk CDC 2016 
 103 
 
2006 PA Salmonella Typhimurium 20 2 0 queso fresco CDC 2016 
2006 CA E. coli O157:H7 6 3 0 raw milk CDC 2016 
2005 OR, WA E. coli O157:H7 18 5
5
 NR raw milk Denny and others 
2008 
2002 IL, IN, OH, 
TN 
Salmonella Typhimurium 62 2 NR raw milk CDC 2003, 
Mazurek and 
others 2004 
2000 PA C. jejuni 3 1 0 raw milk CDC 2016 
2000 NC L. monocytogenes 13 10 NR
6
 Mexican Style 
Cheese 
MacDonald and 
others 2005 
1998 MA Salmonella Typhimurium 47 2 0 raw milk CDC 2016 
1997 WA Salmonella Typhimurium 54 5 NR Mexican Style 
Cheese 
Villar and others 
1999 
1997 CA Salmonella Typhimurium 31 4 NR Mexican Style 
Cheese 
Cody and others 
1999 
1997 CA Salmonella Typhimurium 79 10 NR Mexican Style 
Cheese 
Cody and others 
1999 
1992 OR E. coli O157:H7 14 2 NR Raw Milk Keene and others 
1997 
1
none reported 
2
2 HUS cases reported 
3
 all reported cheese made from raw milk 
4
3 HUS cases reported 
5
4 HUS cases reported 
6
5 stillbirths reported 
